Other spirochaetal diseases

AB1_OTHER_SPIROCHAETAL_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A65-A69 Hospital discharge: ICD-10 — A65-A69 Hospital discharge: ICD-9 — 104\|08[7-7] Hospital discharge: ICD-8 — 08[8-9] Cause of death: ICD-10 — A65-A69 Cause of death: ICD-9 — 104\|08[7-7] Cause of death: ICD-8 — 08[8-9] 3 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints AB1_SYPHILIS_NONVENEREAL AB1_YAWNS AB1_PINTA AB1_RELAP_FEVER AB1_SPIROCHE_OTHER AB1_LYME	14494
6. Filter based on genotype QC (FinnGen only)	14000

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF13

NAME	AB1_OTHER_SPIROCHAETAL_WIDE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	AB1_SYPHILIS_NONVENEREAL\|AB1_YAWNS\|AB1_PINTA\|AB1_RELAP_FEVER\|AB1_SPIROCHE_OTHER\|AB1_LYME
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A6[5-9]
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A6[5-9]
HD_ICD_9	104\|08[7-7]
HD_ICD_8	08[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A6[5-9]
COD_ICD_9	104\|08[7-7]
COD_ICD_8	08[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other spirochaetal diseases based on the number of shared cases.

Similar with more cases:

Certain infectious and parasitic diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14000	8768	5232
Unadjusted period prevalence (%)	2.84	3.11	2.40
Median age at first event (years)	63.07	62.07	64.75

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14494: Matched controls
144940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01CA04

ATC

amoxicillin; systemic

4.0

307.7

13136

102416

A69.2

ICD-10 Finland

Lyme disease

154164.7

307.7

13873

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.6

307.7

799

1803

S12

ICPC

Insect bite/sting

7.4

307.7

3463

5920

S73

ICPC

Pediculosis/skin infestation other

13.2

175.7

167

128

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

823.0

166.1

163

TAB00

NOMESCO Finland

Lumbar puncture

2.6

125.5

761

3016

S29

ICPC

Skin symptom/complaint other

1.7

125.4

2792

17797

J01AA02

ATC

doxycycline; systemic

1.6

124.5

11059

96503

S72

ICPC

Scabies/other acariasis

4.9

122.6

270

555

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

+∞

116.8

112

M01.2*A69.2

ICD-10 Finland

Arthritis in Lyme disease

137.8

115.3

123

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

114.7

2827

18459

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

98.5

2828

19081

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

94.4

1898

11682

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

88.0

619

2625

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

86.3

2489

16752

SPAT1152

SPAT

Removal of foreign body from under the skin

2.9

81.8

404

1438

1048A

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]

+∞

81.3

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

80.6

1138

6290

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

77.3

2476

17021

M25.5

ICD-10 Finland

Pain in joint

1.4

75.1

4361

33686

A98

ICPC

Health maint/preventive medicine

2.6

73.3

14126

135817

S13

ICPC

Animal/human bite

2.4

72.0

508

2155

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

67.6

3673

27933

Z2221

NOMESCO Finland

Medical doctor

1.4

64.9

3542

26921

B88.0

ICD-10 Finland

Other acariasis

6.8

63.3

144

SPAT1262

SPAT

Handing over of treatment supplies

0.6

62.3

950

16030

S06

ICPC

Rash localized

1.9

61.9

768

4060

N73

ICPC

Neurological infection other

23.2

60.8

103

Kela drug reimbursment

Diabetes, insulin-treated

0.7

58.2

1755

25219

A68.9

ICD-10 Finland

Relapsing fever, unspecified

+∞

57.3

S08

ICPC

Skin colour change

1.9

56.3

716

3816

A69.10

ICD-10 Finland

Acute necrotizing ulcerative gingivitis (ANUG)

+∞

55.2

A66.1

ICD-10 Finland

Multiple papillomata and wet crab yaws

+∞

54.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

53.6

6234

52865

G51.0

ICD-10 Finland

Bell palsy

2.4

52.8

368

1553

M04AB01

ATC

probenecid; oral

11.3

51.7

L57.0

ICD-10 Finland

Actinic keratosis

1.6

50.5

1232

7897

SPAT1324

SPAT

Screening procedure

0.6

47.0

1050

16194

205

Kela drug reimbursment

Chronic hypertension

0.7

46.0

1711

23759

L548, A692,

ICD-10 Finland

+∞

45.8

A10BA02

ATC

metformin; oral

0.7

45.1

2007

27000

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.7

44.9

1734

23920

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.7

42.8

1559

21772

A69.9

ICD-10 Finland

Spirochaetal infection, unspecified

+∞

42.7

C03CA01

ATC

furosemide; systemic

0.7

41.4

1889

25358

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

38.8

2631

20458

D22

ICD-10 Finland

Melanocytic naevi

1.8

38.8

646

3739

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

38.1

745

4506

T90

ICPC

Diabetes non-insulin dependent

0.7

38.0

1696

22902

H02AB07

ATC

prednisone; oral

1.4

37.7

1632

11773

M01AH05

ATC

etoricoxib; oral

1.3

36.8

8257

74482

M79.6

ICD-10 Finland

Pain in limb

1.3

36.8

5363

46063

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

36.2

3124

25117

WX725

NOMESCO Finland

Noninvasive ventilation

0.4

35.0

158

4137

R83

ICPC

Respiratory infection other

1.3

34.9

3027

24335

J01FA10

ATC

azithromycin; systemic

1.2

34.8

7527

67426

W86

ICD-10 Finland

Exposure to other specified electric current

4.1

33.4

223

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.7

33.1

1968

25459

WX720

NOMESCO Finland

Own respiration

0.3

32.7

125

3535

D01AE16

ATC

amorolfine; topical

1.4

32.6

1397

10044

R06AX27

ATC

desloratadine; oral

1.3

32.0

3503

28962

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

31.7

846

5522

Z01.7

ICD-10 Finland

Laboratory examination

1.4

31.3

1735

13033

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

31.2

1236

8754

V18

ICD-10 Finland

Pedal cyclist injured in noncollision transport accident

3.6

31.2

101

280

A10AE04

ATC

insulin glargine; parenteral

0.6

30.3

430

7479

J01DB01

ATC

cefalexin; oral

1.3

30.0

11201

105568

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

29.9

1525

11292

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.1

29.8

282

1353

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

29.8

1238

8846

H81

ICPC

Excessive ear wax

1.3

29.7

1922

14781

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

29.6

2760

22330

H10

ICD-10 Finland

Conjunctivitis

1.6

29.6

817

5375

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

29.3

4642

39966

Z71.8

ICD-10 Finland

Other specified counselling

1.3

29.1

3731

31365

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

28.7

2927

23939

Z20.7

ICD-10 Finland

Contact with and exposure to pediculosis, acariasis and other infestations

5.8

28.3

D19

ICPC

Teeth/gum symptom/complaint

1.3

28.2

3420

28547

WX704

NOMESCO Finland

Intubation

0.6

28.0

386

6775

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

0.7

27.8

1018

14310

A66.3

ICD-10 Finland

Hyperkeratosis of yaws

+∞

27.1

EB1AA, ,

SPAT

1.5

26.9

781

5192

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

26.8

555

3409

J20

ICD-10 Finland

Acute bronchitis

1.4

26.3

1183

8565

A10AC01

ATC

insulin (human); parenteral

0.5

26.0

263

5062

M79.1

ICD-10 Finland

Myalgia

1.3

25.8

1682

12928

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

25.7

693

4533

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

25.4

3602

42065

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

4.6

25.3

132

R01AD09

ATC

mometasone; nasal

1.2

25.2

5703

50663

H02

ICPC

Hearing complaint

1.4

25.2

1523

11577

I50.9

ICD-10 Finland

Heart failure, unspecified

0.6

25.0

575

8887

M01.2

ICD-10 Finland

Arthritis in Lyme disease

58.1

25.0

S82

ICPC

Naevus/mole

1.3

24.5

1552

11873

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

0.7

24.5

811

11633

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

24.4

938

6599

R74

ICPC

Upper respiratory infection acute

1.2

24.4

3735

31903

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.5

24.2

156

638

A28

ICPC

Limited function/disability NOS

0.7

23.7

963

13317

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

23.5

302

5411

S21

ICPC

Skin texture symptom/complaint

1.3

23.5

1625

12593

R05

ICD-10 Finland

Cough

1.3

23.4

2538

20850

SPAT1254

SPAT

Administration of medicine

0.7

23.1

872

12216

C01CA24

ATC

epinephrine; parenteral

1.5

23.1

693

4641

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

23.0

2695

22336

R51.80

ICD-10 Finland

Headache

1.3

23.0

1746

13707

0879X

ICD-9 Finland

Relapsing fever, unspecified

+∞

22.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

22.9

5257

46637

J05AB11

ATC

valaciclovir; oral

1.3

22.9

1672

13053

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

0.6

22.9

524

8106

I50.0

ICD-10 Finland

Congestive heart failure

0.5

22.8

195

3968

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

0.5

22.7

229

4413

R01AD08

ATC

fluticasone; nasal

1.2

22.5

3449

29410

R51

ICD-10 Finland

Headache

1.6

22.5

610

3994

OAB50, ,

SPAT

0.5

22.5

217

4241

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

22.5

6040

54318

TPH07

NOMESCO Finland

Cathetrisation of artery

0.7

22.5

632

9362

SDA03

NOMESCO Finland

Periodontal treatment

1.2

22.3

4967

43908

D01BA02

ATC

terbinafine; oral

1.2

22.1

2973

25004

D06BB10

ATC

imiquimod; topical

1.6

22.0

551

3545

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

22.0

2680

22293

GD1AA, ,

SPAT

1.4

21.9

1288

9740

A66.2

ICD-10 Finland

Other early skin lesions of yaws

+∞

21.9

R4110

NOMESCO Finland

Physiotherapy

1.2

21.8

3256

27682

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.4

21.7

139

3140

SPAT1222

SPAT

Counselling/guidance promoting independent living

0.7

21.3

912

12506

M03BX02

ATC

tizanidine; oral

1.2

21.3

8084

74754

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

21.0

1111

8258

A10AB05

ATC

insulin aspart; parenteral

0.6

20.9

336

5663

A69

ICD-10 Finland

Other spirochaetal infections

+∞

20.8

Z01.2

ICD-10 Finland

Dental examination

1.2

20.8

5684

51069

Z51.5

ICD-10 Finland

Palliative care

0.6

20.6

335

5630

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

20.4

1118

8359

A10BB12

ATC

glimepiride; oral

0.5

20.4

225

4213

SPAT1097

SPAT

Recording of ECG

0.7

20.3

962

12977

130

Kela drug reimbursment

Malignant tumour

0.6

20.1

431

6767

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

19.9

579

8526

S18

ICPC

Laceration/cut

1.2

19.9

5594

50330

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

19.7

1312

10096

B02

ICD-10 Finland

Zoster [herpes zoster]

1.6

19.6

465

2955

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

19.6

547

3607

H93.1

ICD-10 Finland

Tinnitus

1.4

19.4

773

5471

K08.80

ICD-10 Finland

Toothache NOS

1.4

19.4

961

7068

R52.9

ICD-10 Finland

Pain, unspecified

1.4

19.3

1102

8291

M01AE02

ATC

naproxen; oral, rectal

1.2

19.1

7126

65523

A23

ICPC

Risk factor NOS

1.4

19.1

900

6566

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.7

19.0

342

2026

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

0.7

18.9

1084

14221

SPAT1360

SPAT

Extensive global examination

1.4

18.9

742

5240

A97

ICPC

No disease

1.3

18.8

1995

16302

-31

ICPC

Medical examin/health eval partial

0.6

18.7

305

5122

M54

ICD-10 Finland

Dorsalgia

1.3

18.7

1355

10551

G04CA01

ATC

alfuzosin; oral

1.3

18.7

1132

8590

HA1RA, ,

SPAT

1.6

18.5

483

3137

G63.0

ICD-10 Finland

Polyneuropathy in infectious and parasitic diseases classified elsewhere

30.0

18.3

HARJA, ,

NOMESCO Finland

3.8

18.1

142

UDC00

NOMESCO Finland

Ear microscopy

0.6

18.1

374

5928

L30

ICD-10 Finland

Other dermatitis

1.8

18.1

250

1371

R42

ICD-10 Finland

Dizziness and giddiness

1.2

18.1

2534

21341

A10BH01

ATC

sitagliptin; oral

0.7

18.0

515

7609

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

18.0

413

2605

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

18.0

1031

7760

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.8

17.9

252

1390

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.6

17.9

344

5544

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

17.8

2302

19220

L17

ICPC

Foot/toe symptom/complaint

1.2

17.8

3400

29502

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

17.8

2916

24946

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

17.8

978

7315

CS494

NOMESCO Finland

Other visual field testing

1.8

17.7

273

1548

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

17.6

1069

8118

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

17.5

514

3426

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

17.5

2804

23925

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

17.5

424

6483

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

0.5

17.5

139

2897

X58

ICD-10 Finland

Exposure to other specified factors

1.3

17.3

1537

12291

N05AA02

ATC

levomepromazine; systemic

0.5

17.2

119

2608

Z04.3

ICD-10 Finland

Examination and observation following other accident

1.9

17.1

220

1180

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

17.1

1238

9637

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

17.0

4324

38444

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

16.9

1873

15370

WX110, ,

SPAT

1.4

16.8

638

4478

SPAT1263

SPAT

Sampling

0.8

16.7

4018

45134

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

16.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

16.6

3221

27967

EB1SA, ,

SPAT

1.5

16.5

572

3945

A06AD11

ATC

lactulose; oral

0.7

16.3

836

11157

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

16.2

483

3232

N05AX08

ATC

risperidone; systemic

0.6

16.1

352

5506

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

16.1

993

7554

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

16.0

1295

10232

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

16.0

3700

32604

L08

ICPC

Shoulder symptom/complaint

1.2

15.9

2507

21338

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

15.7

5715

52147

A69.0

ICD-10 Finland

Necrotizing ulcerative stomatitis

+∞

15.6

G01

ICD-10 Finland

Meningitis in bacterial diseases classified elsewhere

160.2

15.5

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

15.4

481

3252

NG2AA

NOMESCO Finland

Patella X-ray examination

1.7

15.3

301

1830

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

15.3

884

6663

J01MA01

ATC

ofloxacin; systemic

1.4

15.2

806

5990

R50.9

ICD-10 Finland

Fever, unspecified

1.3

15.2

1571

12781

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

15.2

609

4318

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

15.2

742

5445

WX002

NOMESCO Finland

Sedation and analgesia

1.2

15.1

2158

18178

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

15.1

528

3649

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

15.1

579

4073

J31.0

ICD-10 Finland

Chronic rhinitis

1.3

15.1

913

6926

A10AE05

ATC

insulin detemir; parenteral

0.6

15.0

212

3695

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

15.0

1534

12469

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

14.8

1584

12936

R06AX22

ATC

ebastine; oral

1.2

14.8

1934

16146

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

14.7

12320

119388

A10BB01

ATC

glibenclamide; oral

0.4

14.7

1631

M01AB05

ATC

diclofenac; systemic, rectal

1.2

14.6

8497

79992

B35.1

ICD-10 Finland

Tinea unguium

1.4

14.6

669

4855

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

14.6

A66.9

ICD-10 Finland

Yaws, unspecified

+∞

14.6

SPAT1193

SPAT

Pap smear

0.7

14.4

494

7053

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.4

14.4

667

4853

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

12.5

14.3

H02AB06

ATC

prednisolone; systemic

1.2

14.3

5742

52651

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

1.8

14.2

209

1171

R07.3

ICD-10 Finland

Other chest pain

1.3

14.1

1074

8411

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

14.1

2923

25467

L03

ICPC

Low back symptom/complaint

1.2

14.1

3200

28094

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

14.0

1036

8085

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

0.7

14.0

458

6593

R21

ICPC

Throat symptom/complaint

1.2

13.9

2257

19235

H92.0

ICD-10 Finland

Otalgia

1.4

13.8

618

4471

G44.2

ICD-10 Finland

Tension-type headache

1.2

13.7

1499

12267

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

13.7

2961

25887

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

13.7

6426

59499

H01.0

ICD-10 Finland

Blepharitis

1.4

13.7

677

4979

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

13.6

728

5419

F29

ICPC

Eye symptom/complaint other

1.3

13.6

1015

7928

M67.4

ICD-10 Finland

Ganglion

1.4

13.6

711

5278

N02AA05

ATC

oxycodone; systemic

0.8

13.5

1199

14885

L01

ICPC

Neck symptom/complaint

1.2

13.4

1723

14346

H60

ICD-10 Finland

Otitis externa

1.4

13.4

522

3685

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

13.4

2306

19763

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.0

13.3

150

772

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

13.3

3231

28505

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

13.3

853

6527

XF640, ,

NOMESCO Finland

1.7

13.3

253

1526

XQ855

NOMESCO Finland

Skin temperature measurement

3.1

13.2

170

L90.4

ICD-10 Finland

Acrodermatitis chronica atrophicans

13.8

13.2

Z00.0

ICD-10 Finland

General medical examination

1.2

13.2

2112

17972

SPAT1395

SPAT

Health check-up of persons outside student and working life

0.4

13.0

1574

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.8

13.0

175

955

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

13.0

1095

8687

R00.2

ICD-10 Finland

Palpitations

1.3

13.0

829

6337

SPAT1100

SPAT

Long-term monitoring of blood pressure

0.6

13.0

295

4569

J01

ICD-10 Finland

Acute sinusitis

1.4

12.9

560

4029

N18.8

ICD-10 Finland

Other chronic renal failure

0.3

12.9

1332

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

12.9

294

4550

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

12.8

855

6577

N05AH03

ATC

olanzapine; systemic

0.6

12.8

289

4485

R01AD58

ATC

fluticasone, combinations; nasal

1.2

12.8

2768

24180

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

12.8

690

5146

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.7

12.6

229

1364

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

12.6

1327

10811

A04AA02

ATC

granisetron; systemic, transdermal

0.7

12.5

359

5301

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

12.5

2398

20731

K30

ICD-10 Finland

Functional dyspepsia

1.3

12.5

1214

9800

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.3

12.5

1188

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.5

12.4

147

2689

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

12.4

808

6198

A02BC05

ATC

esomeprazole; systemic

1.1

12.3

4899

44755

L15

ICPC

Knee symptom/complaint

1.2

12.3

2738

23965

H02AB04

ATC

methylprednisolone; systemic

1.2

12.3

1569

13056

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

12.3

269

4198

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

12.2

1386

N30

ICD-10 Finland

Cystitis

1.3

12.2

825

6361

SPAT1301

SPAT

No procedures

0.9

12.2

2778

31512

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

12.2

3563

31855

XX3DW

NOMESCO Finland

Time consuming IT work

0.8

12.1

713

9336

SPAT1304

SPAT

Counselling and guidance related to ageing

0.7

12.1

305

4622

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.3

12.0

1074

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

1.9

12.0

141

738

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

12.0

290

4431

C09AA05

ATC

ramipril; oral

0.8

12.0

1933

22580

M15

ICD-10 Finland

Polyarthrosis

1.4

12.0

511

3668

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

11.9

5087

46667

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

11.9

1075

8604

A10BK03

ATC

empagliflozin; oral

0.7

11.9

601

8045

EBA15

NOMESCO Finland

Extraction of multiple teeth

0.5

11.9

143

2600

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.1

11.9

5382

49564

H61.2

ICD-10 Finland

Impacted cerumen

1.3

11.8

660

4948

R35

ICD-10 Finland

Polyuria

1.4

11.8

643

4805

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

11.7

766

9886

C03DA01

ATC

spironolactone; oral

0.8

11.7

713

9291

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

0.6

11.7

188

3157

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.7

11.6

324

4809

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

11.6

908

7139

K03.66

ICD-10 Finland

Tooth plaque

1.3

11.6

749

5741

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

11.5

5270

48536

A67.0

ICD-10 Finland

Primary lesions of pinta

+∞

11.5

A06AC51

ATC

ispaghula, combinations; oral

1.4

11.4

488

3504

L13

ICPC

Hip symptom/complaint

1.2

11.3

2013

17279

M01AX05

ATC

glucosamine; oral

1.2

11.3

2075

17859

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

0.5

11.3

135

2456

A02BC04

ATC

rabeprazole; oral

1.3

11.2

926

7328

HMAK, ,

NOMESCO Finland

0.8

11.1

784

10020

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

11.1

1019

12611

R01AD12

ATC

fluticasone furoate; nasal

1.1

11.1

3622

32596

M75

ICD-10 Finland

Shoulder lesions

1.4

11.1

439

3111

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

11.1

947

7529

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.6

11.1

203

3299

M77.4

ICD-10 Finland

Metatarsalgia

1.3

11.0

620

4655

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.3

11.0

715

5481

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

0.8

11.0

1188

14444

N17.9

ICD-10 Finland

Acute renal failure, unspecified

0.6

11.0

137

2465

SPAT1229

SPAT

Assessment of need for aid

0.7

11.0

403

5682

HA1AE, ,

SPAT

1.6

11.0

272

1753

R06AE07

ATC

cetirizine; oral

1.1

10.9

5308

49016

A10BD07

ATC

metformin and sitagliptin; systemic

0.6

10.9

180

3002

TK800

NOMESCO Finland

Hemodialysis

0.4

10.9

1226

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

2.3

10.9

370

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.9

10.8

122

631

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

10.8

336

2275

SPAT1245

SPAT

Provision of support and information to patient’s family members

0.5

10.8

122

2255

B01AF01

ATC

rivaroxaban; oral

1.2

10.8

1299

10741

R52.2

ICD-10 Finland

Other chronic pain

1.5

10.8

365

2514

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

1.7

10.7

209

1271

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

10.6

1078

8745

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.4

10.6

1483

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

10.6

1104

8983

UJD10, ,

SPAT

1.6

10.6

224

1391

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

10.6

120

2218

K58

ICD-10 Finland

Irritable bowel syndrome

1.6

10.6

247

1571

A10AA02, ,

ATC

0.5

10.6

1754

J45

ICD-10 Finland

Asthma

1.2

10.6

1082

8788

J05AB01

ATC

aciclovir; systemic

1.2

10.5

2396

20983

TPH04

NOMESCO Finland

Cathetrisation of vein

0.8

10.5

1794

20874

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.6

10.5

242

1536

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.1

10.5

3814

34559

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

10.4

2018

17440

A69.8

ICD-10 Finland

Other specified spirochaetal infections

+∞

10.4

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.1

10.4

442

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

0.6

10.4

162

2741

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.0

10.4

113

577

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.2

10.3

1512

12743

J37.0

ICD-10 Finland

Chronic laryngitis

1.5

10.3

327

2223

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.7

10.3

300

4410

G04CB01

ATC

finasteride; oral

1.3

10.3

838

6624

E03

ICD-10 Finland

Other hypothyroidism

1.3

10.3

616

4672

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.5

10.2

338

2316

MAX99

NOMESCO Finland

Assistance to normal delivery

1.4

10.2

545

4062

M23

ICD-10 Finland

Internal derangement of knee

1.6

10.2

234

1483

QBE99, ,

SPAT

2.2

10.1

401

XF402

NOMESCO Finland

ECG with work load test

1.2

10.1

1068

8707

SPAT1148

SPAT

Treatment of chronic ulcer or burn

0.8

10.1

876

10911

P72

ICPC

Schizophrenia

0.3

10.1

1035

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

1.7

10.1

165

959

PH2AE, ,

SPAT

1.7

10.1

171

1004

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

10.0

1872

16127

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

0.1

10.0

408

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

10.0

162

2712

N05AD01

ATC

haloperidol; systemic

0.5

10.0

1665

EBA00

NOMESCO Finland

Extraction of tooth

0.9

10.0

3358

37133

SFB40

NOMESCO Finland

Filling of four surfaces reproduced outside mouth

2.3

10.0

333

J01MA06

ATC

norfloxacin; oral

1.2

9.9

1341

11215

K59.0

ICD-10 Finland

Constipation

1.4

9.9

519

3857

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

1.8

9.9

142

794

I50.1

ICD-10 Finland

Left ventricular failure

0.6

9.9

155

2617

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

9.9

668

5153

SPAT1377

SPAT

Polysomnography

0.6

9.9

133

2337

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.2

9.9

695

HAMTE, ,

NOMESCO Finland

0.2

9.9

445

Z3226

NOMESCO Finland

Physiotherapist

1.2

9.8

1928

16677

QCE99, ,

SPAT

3.3

9.8

110

C09CA06

ATC

candesartan; oral

1.2

9.8

2626

23276

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

9.8

648

4984

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.5

9.8

304

2059

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.4

9.8

477

3506

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.5

9.8

341

2364

EB1CA, ,

SPAT

2.1

9.7

447

A10BJ06

ATC

semaglutide; parenteral

0.7

9.7

247

3731

EBA00, ,

SPAT

1.5

9.7

269

1780

L53.8

ICD-10 Finland

Other specified erythematous conditions

3.0

9.7

142

OAB95, ,

SPAT

1.3

9.6

650

5012

H91.1

ICD-10 Finland

Presbycusis

1.4

9.6

504

3745

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.3

9.6

535

4012

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.7

9.6

251

3766

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.6

9.6

213

1341

J02AC01

ATC

fluconazole; systemic

1.1

9.6

4735

43680

R12

ICD-10 Finland

Heartburn

1.3

9.6

828

6596

R53

ICD-10 Finland

Malaise and fatigue

1.2

9.5

2495

22071

J18.9

ICD-10 Finland

Pneumonia, unspecified

0.8

9.5

1852

21327

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

1.9

9.5

106

547

R03BC03

ATC

nedocromil; inhalant

1.3

9.5

693

5401

D07AD01

ATC

clobetasol; topical

1.2

9.5

1822

15728

H25.0

ICD-10 Finland

Senile incipient cataract

1.3

9.5

616

4725

M19

ICD-10 Finland

Other arthrosis

1.6

9.5

222

1414

A26.0

ICD-10 Finland

Cutaneous erysipeloid

10.0

9.5

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

9.4

1575

13433

B01AB10

ATC

tinzaparin; parenteral

0.8

9.4

686

8731

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

9.4

579

4408

H22.0*A69.2

ICD-10 Finland

Iridocyclitis in Lyme disease

100.1

9.4

A66.0

ICD-10 Finland

Initial lesions of yaws

+∞

9.4

H58.8*A69.2

ICD-10 Finland

Ophthalmopathy in Lyme disease

+∞

9.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

9.4

2017

17576

ZY010, ,

SPAT

1.8

9.4

136

764

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

9.3

377

2686

H02AB02

ATC

dexamethasone; systemic

0.8

9.3

826

10262

J01AA04

ATC

lymecycline; systemic

1.2

9.3

1334

11222

A10BH05

ATC

linagliptin; oral

0.6

9.2

217

3329

R03BA02

ATC

budesonide; inhalant

1.2

9.2

1908

16571

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.5

9.2

290

1970

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.4

9.2

1061

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.2

9.1

1141

9468

F38

ICPC

Eye, Other laboratory test NEC

1.8

9.1

137

778

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.4

9.1

387

2782

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.5

9.1

312

2157

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.4

9.1

1185

EB4VA, ,

NOMESCO Finland

1.2

9.1

1112

9208

TUPAE, ,

NOMESCO Finland

4.4

9.1

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

9.0

6411

67975

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.1

9.0

393

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.2

9.0

946

7705

A10AE06

ATC

insulin degludec; parenteral

0.6

9.0

132

2265

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.5

9.0

1737

R03AC03

ATC

terbutaline; inhalant

1.2

9.0

1447

12300

SPAT1079

SPAT

Echocardiography

0.3

8.9

716

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

8.9

2932

26340

DHB50

NOMESCO Finland

Turbinoplasty

1.5

8.9

241

1587

L50

ICD-10 Finland

Urticaria

1.7

8.9

158

940

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

8.8

362

2585

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.3

8.8

720

5693

A10AB01

ATC

insulin (human); parenteral

0.6

8.8

115

2037

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.4

8.8

329

2310

G04BD12

ATC

mirabegron; oral

1.2

8.8

1191

9958

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

8.8

581

4468

SFA20

NOMESCO Finland

Two-surface restoration

1.1

8.8

7262

68805

Z24.1

ICD-10 Finland

Need for immunization against arthropod-borne viral encephalitis

2.6

8.8

190

SPAT1279

SPAT

Preparation of immediate hospitalisation

0.2

8.8

393

A84.9

ICD-10 Finland

Tick-borne viral encephalitis, unspecified

10.7

8.8

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

8.8

996

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

8.8

1223

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

0.5

8.8

1576

J01MA02

ATC

ciprofloxacin; systemic

1.1

8.8

4371

40292

J02AC02

ATC

itraconazole; systemic

1.2

8.7

1944

16981

N17

ICPC

Vertigo/dizziness

1.2

8.7

1213

10172

T36

ICD-10 Finland

Poisoning by systemic antibiotics

0.6

8.7

187

2924

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.2

8.7

1123

9347

N05AF03

ATC

chlorprothixene; systemic

0.5

8.7

1613

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

0.4

8.7

1248

D01

ICPC

Abdominal pain/cramps general

1.2

8.7

1196

10018

L20

ICPC

Joint symptom/complaint NOS

1.4

8.7

363

2602

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

8.7

841

6789

S01

ICPC

Pain/tenderness of skin

1.4

8.7

435

3213

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

0.7

8.7

337

4698

B35.3

ICD-10 Finland

Tinea pedis

1.4

8.7

418

3069

J01FA09

ATC

clarithromycin; systemic

1.1

8.6

3611

32934

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

0.5

8.6

1700

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

0.2

8.6

391

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

8.6

203

3109

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

1.9

8.6

109

588

N05AC02

ATC

thioridazine; oral

0.4

8.6

1115

M54.5

ICD-10 Finland

Low back pain

1.1

8.6

4137

38050

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

8.5

1890

16500

C10AA01

ATC

simvastatin; oral

0.9

8.5

3876

42161

SPAT1139

SPAT

Nutrition survey

0.6

8.5

122

2104

WX723

NOMESCO Finland

CPAP therapy

0.6

8.5

186

2896

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

8.5

9189

88236

AN1

Coronary angiography

0.8

8.5

640

8107

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

8.5

681

5377

A12BA01

ATC

potassium chloride; oral

0.6

8.4

128

2174

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

8.4

1170

13876

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.3

8.4

504

3828

R06AE09

ATC

levocetirizine; oral

1.2

8.3

1511

12977

A66

ICD-10 Finland

Yaws

+∞

8.3

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.3

8.3

691

5478

NH3AA, ,

SPAT

1.4

8.3

439

3270

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

8.3

403

2963

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

8.3

330

4581

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

0.7

8.3

227

3371

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.4

8.3

294

2048

H00.00

ICD-10 Finland

Hordeolum

1.4

8.2

411

3035

S59

ICPC

Skin, Other therap proced/minor surg NEC

1.6

8.2

163

1000

F20

ICD-10 Finland

Schizophrenia

0.1

8.2

312

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

8.2

1592

13754

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.4

8.1

1020

EB1HA, ,

SPAT

1.6

8.1

179

1126

XA402

NOMESCO Finland

ENMG

1.5

8.1

238

1596

R01BA01

ATC

phenylpropanolamine; oral

1.3

8.1

521

3994

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

2.6

8.1

163

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.5

8.1

247

1671

S83

ICD-10 Finland

Dislocation, sprain and strain of joints and ligaments of knee

1.6

8.1

180

1137

A11

ICPC

Chest pain NOS

1.2

8.0

800

6479

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

8.0

522

4009

H40.1

ICD-10 Finland

Primary open-angle glaucoma

2.9

8.0

130

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.3

8.0

557

4317

TNG10

NOMESCO Finland

Puncture of knee

1.8

8.0

116

653

D06BB03

ATC

aciclovir; topical

1.3

8.0

455

3430

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.3

8.0

573

4463

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1.8

7.9

116

655

SPAT1131

SPAT

Colonoscopy

0.6

7.9

130

2161

L50.0

ICD-10 Finland

Allergic urticaria

1.5

7.9

247

1680

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.4

7.9

366

2673

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.6

7.9

176

1112

A10BK01

ATC

dapagliflozin; oral

0.7

7.9

414

5500

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.4

7.8

285

1996

E0000UV, ,

ATC

1.1

7.8

4842

45101

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.4

7.8

287

2013

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.2

7.8

898

7390

R4120

NOMESCO Finland

Occupational therapy

1.3

7.8

629

4971

R23

ICD-10 Finland

Other skin changes

1.8

7.8

111

622

M02.8

ICD-10 Finland

Other reactive arthropathies

2.4

7.8

208

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.3

7.8

706

A86

ICD-10 Finland

Unspecified viral encephalitis

2.5

7.8

184

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.6

7.8

152

2424

C09BA02

ATC

enalapril and diuretics; systemic

0.8

7.8

453

5932

A10AD05

ATC

insulin aspart; parenteral

0.3

7.8

751

B35.4

ICD-10 Finland

Tinea corporis

1.7

7.8

125

726

N05AH02

ATC

clozapine; systemic

0.4

7.7

969

N05BA06

ATC

lorazepam; systemic, sublingual

0.7

7.7

240

3474

ZXH09, ,

SPAT

1.5

7.7

210

1390

KAY20, ,

NOMESCO Finland

1.7

7.7

121

699

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

0.7

7.7

212

3139

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

7.6

574

4496

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

0.6

7.6

144

2315

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.5

7.6

1306

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

7.6

698

5603

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

0.2

7.6

381

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.6

7.6

188

1217

R03DC03

ATC

montelukast; oral

1.2

7.6

1772

15527

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.6

7.6

175

2688

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.2

7.6

920

7614

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

7.6

326

2353

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.2

7.5

1176

9968

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.4

7.5

340

2473

DAX08

NOMESCO Finland

Fitting of hearing aid

1.3

7.5

459

3498

E66.01

ICD-10 Finland

Obesity due to excess calories

0.8

7.5

584

7365

R49.03

ICD-10 Finland

Atrophic dysphonia

1.8

7.5

105

586

C01DA14

ATC

isosorbide mononitrate; oral

0.8

7.5

859

10379

S97

ICPC

Chronic ulcer skin

0.7

7.5

305

4211

H81.3

ICD-10 Finland

Other peripheral vertigo

1.4

7.4

258

1791

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

7.4

1824

16045

SPAT1305

SPAT

Counselling and guidance related to physical exercise

0.8

7.4

592

7441

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.8

7.4

427

5596

G03.9

ICD-10 Finland

Meningitis, unspecified

2.8

7.3

120

S04

ICPC

Lump/swelling localized

1.2

7.3

1039

8730

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.3

7.3

401

3007

R03AK07

ATC

formoterol and budesonide; inhalant

1.1

7.3

2256

20158

C50

ICD-10 Finland

Malignant neoplasm of breast

1.5

7.3

242

1665

C07FB02

ATC

metoprolol and felodipine; systemic

0.6

7.3

1703

A67.1

ICD-10 Finland

Intermediate lesions of pinta

+∞

7.3

Z25.1

ICD-10 Finland

Need for immunization against influenza

0.7

7.3

308

4229

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.2

7.3

764

6227

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.1

7.3

298

188

Kela drug reimbursment

Psychosis requiring demanding treatment

0.2

7.3

506

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.2

7.3

810

6645

OAA67, ,

SPAT

1.2

7.2

1386

11956

N04AA02

ATC

biperiden; systemic

0.5

7.2

1067

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.5

7.2

186

1215

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.3

7.2

648

N32.0

ICD-10 Finland

Bladder-neck obstruction

2.1

7.2

312

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.9

7.2

1479

16986

ZXC60

NOMESCO Finland

Application of heat

1.6

7.2

147

910

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

7.2

1786

15723

XF610

NOMESCO Finland

Measurement of pulsvariation

3.7

7.2

U02

ICPC

Urinary frequency/urgency

1.2

7.2

1476

12809

Z04

ICD-10 Finland

Examination and observation for other reasons

1.6

7.2

146

904

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

7.1

1635

14304

A11CC03

ATC

alfacalcidol; systemic

0.5

7.1

1356

ZXE20

NOMESCO Finland

More than three and less than five hours

0.8

7.1

970

11532

NG1AA, ,

SPAT

1.3

7.1

645

5172

C10AC01

ATC

colestyramine; oral

1.4

7.1

252

1758

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

0.2

7.1

382

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.2

7.1

966

8088

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.8

7.1

889

10649

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

0.7

7.1

208

3040

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

0.6

7.1

129

2086

WX290, ,

SPAT

1.4

7.0

325

2374

QAE99, ,

SPAT

1.9

7.0

425

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.8

7.0

534

6754

R07.0

ICD-10 Finland

Pain in throat

1.3

7.0

667

5379

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

0.6

7.0

137

2181

SPAT1104

SPAT

Monitoring of emergency patient

0.7

7.0

371

4921

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

1.6

7.0

133

809

XQ800

NOMESCO Finland

Prick test

1.2

7.0

723

5884

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

0.4

7.0

741

N02CC03

ATC

zolmitriptan; nasal, oral

1.3

7.0

507

3957

WX702

NOMESCO Finland

Supraglottic ventilation device

0.7

7.0

326

4404

H57.1

ICD-10 Finland

Ocular pain

1.4

7.0

341

2515

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

0.8

6.9

428

5559

NG1BG, ,

SPAT

1.4

6.9

329

2414

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

0.6

6.9

111

1854

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

1.4

6.9

260

1833

SPAT1281

SPAT

Other administrative function

0.8

6.9

481

6150

WX872

NOMESCO Finland

Intensive care

0.7

6.9

252

3544

R01AD05

ATC

budesonide; nasal

1.2

6.9

741

6056

J96.1

ICD-10 Finland

Chronic respiratory failure

0.5

6.9

1032

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

0.4

6.9

949

F20.10

ICD-10 Finland

Raise schizophrenia continuously

0.0

6.9

203

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

0.5

6.9

1017

R51.81

ICD-10 Finland

Facial pain NOS

1.5

6.8

219

1500

A41.9

ICD-10 Finland

Sepsis, unspecified

0.6

6.8

133

2117

L01CB01

ATC

etoposide; systemic

0.1

6.8

252

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.2

6.8

736

6021

EBA05, ,

SPAT

1.6

6.8

160

1027

K05.18

ICD-10 Finland

Chronic gingivitis

1.3

6.8

643

5186

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.5

6.8

1305

AN2

Balloon angioplasty, including several vessels

0.6

6.7

1549

D82

ICPC

Teeth/gum disease

1.1

6.7

4221

39273

G01AA10

ATC

clindamycin; vaginal

1.2

6.7

1524

13324

H29

ICPC

Ear symptom/complaint other

1.2

6.7

1150

9830

R19.4

ICD-10 Finland

Change in bowel habit

1.4

6.7

250

1761

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

1.6

6.7

142

888

D06BX02

ATC

ingenol mebutate; topical

1.7

6.7

105

607

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.8

6.7

382

5011

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

0.2

6.7

332

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

1.6

6.7

128

781

DFF59

NOMESCO Finland

Other assessment of balance

1.8

6.7

534

H3601, E113,

ICD-10 Finland

0.4

6.7

694

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

6.7

1180

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.4

6.6

271

1940

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

6.6

1034

8767

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.5

6.6

182

1208

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

0.1

6.6

269

NH1AA, ,

SPAT

1.4

6.6

230

1600

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.3

6.6

481

3756

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.7

6.6

158

2405

ULC02

NOMESCO Finland

Hysteroscopy

1.3

6.6

478

3730

Z37.0

ICD-10 Finland

Single live birth

1.3

6.6

575

4591

D23

ICD-10 Finland

Other benign neoplasms of skin

1.5

6.6

207

1412

A10AB04

ATC

insulin lispro; parenteral

0.6

6.6

119

1928

N64.5

ICD-10 Finland

Other signs and symptoms in breast

1.5

6.6

211

1445

J01DC02

ATC

cefuroxime; systemic

1.3

6.6

518

4087

SPAT1216

SPAT

Assessment of functional ability

0.8

6.6

1108

12925

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

6.5

374

2827

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

6.5

1254

10823

A10AA01, ,

ATC

0.6

6.5

1458

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.4

6.5

334

2483

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.9

6.5

4150

44481

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

0.8

6.5

1168

13556

C09AA02

ATC

enalapril; systemic

0.9

6.5

1439

16430

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.1

6.5

1923

17133

M20.2

ICD-10 Finland

Hallux rigidus

1.4

6.5

302

2212

N76.0

ICD-10 Finland

Acute vaginitis

1.3

6.5

519

4104

C08CA01

ATC

amlodipine; oral

0.9

6.5

3598

38828

N05AB03

ATC

perphenazine; systemic, rectal

0.6

6.4

149

2281

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.6

6.4

1425

A49.9

ICD-10 Finland

Bacterial infection, unspecified

0.8

6.4

710

8607

H36.01

ICD-10 Finland

Diabetic maculopathy

0.4

6.4

665

JN1AE, ,

SPAT

1.4

6.4

285

2073

M25.9

ICD-10 Finland

Joint disorder, unspecified

1.8

6.4

549

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

6.4

1306

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.1

6.4

1765

15654

L50.9

ICD-10 Finland

Urticaria, unspecified

1.3

6.4

341

2553

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.4

6.4

313

2313

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

6.4

6802

64843

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.1

6.3

3189

29321

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.3

6.3

587

SPD00

NOMESCO Finland

Mucosa borne complete denture

0.3

6.3

602

NA3BG, ,

SPAT

1.3

6.3

347

2607

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

1.5

6.3

182

1221

H25.8

ICD-10 Finland

Other senile cataract

1.2

6.3

929

7840

B01AA03

ATC

warfarin; systemic

0.9

6.3

1246

14346

K03.08

ICD-10 Finland

Other wear and tear of the teeth

1.4

6.3

249

1776

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.3

6.3

441

3431

N05AX12

ATC

aripiprazole; systemic

0.7

6.3

163

2436

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

1.3

6.3

325

2422

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

1.8

6.3

479

A67.9

ICD-10 Finland

Pinta, unspecified

+∞

6.2

1048X

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[INFECTIO SPIROCHAETALES ALIA DEFINITA]

+∞

6.2

M02AA07

ATC

piroxicam; topical

1.1

6.2

4003

37261

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

0.5

6.2

1061

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.2

6.2

610

4939

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.4

6.2

671

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.6

6.2

128

2010

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

6.2

1185

10223

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

1.7

6.2

103

606

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

0.2

6.2

297

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

2.0

6.2

304

R30.1

ICD-10 Finland

Vesical tenesmus

1.5

6.2

192

1309

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.7

6.2

195

2807

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

0.7

6.1

195

2806

L29

ICPC

Musculoskeletal sympt/complt other

1.2

6.1

841

7048

H91

ICD-10 Finland

Other hearing loss

1.8

6.1

482

S72.0

ICD-10 Finland

Fracture of neck of femur

0.6

6.1

120

1904

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.5

6.1

166

1101

N63

ICD-10 Finland

Unspecified lump in breast

1.2

6.1

614

4987

WX320

NOMESCO Finland

Spinalanesthesy

1.1

6.1

2617

23846

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

0.2

6.1

450

M54.3

ICD-10 Finland

Sciatica

1.2

6.1

576

4646

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

6.1

1299

11305

U09

ICD-10 Finland

Post COVID-19 condition

1.8

6.1

447

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

0.6

6.1

1604

S83.2

ICD-10 Finland

Tear of meniscus, current

1.2

6.1

671

5506

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

1.7

6.1

113

686

L12

ICPC

Hand/finger symptom/complaint

1.1

6.1

1699

15079

160

Kela drug reimbursment

exenatide

0.5

6.1

1234

RTGOM, ,

NOMESCO Finland

3.0

6.1

PE1AT

NOMESCO Finland

Femoral artery PTA

0.3

6.1

573

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.2

6.0

603

4893

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

1.3

6.0

425

3307

K06.01

ICD-10 Finland

General gingival retraction

1.8

6.0

412

A12AA04

ATC

calcium carbonate; oral

0.4

6.0

804

E87.5

ICD-10 Finland

Hyperkalaemia

0.5

6.0

859

N05AF05

ATC

zuclopenthixol; systemic

0.3

6.0

494

M25

ICD-10 Finland

Other joint disorders, not elsewhere classified

2.1

6.0

267

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

0.2

6.0

332

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

357

352

10.37

319.17

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3542

7895

5.61

307.65

3.2

2.2

31.47

20.15

au/ml

8.46

565

507

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

377

384

10.05

307.65

1.1

1150.20

476.32

ng/l

0.80

107

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3106

7287

5.15

307.65

1.7

1.2

64.42

42.93

au/ml

7.37

523

266

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

339

401

8.63

264.06

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

481

1192

4.14

172.73

1.1

32.27

3.64

au/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2604

15154

1.88

164.44

4.6

4.5

32.91

32.40

1.38

1542

10527

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

200

231

8.77

158.64

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

411

1049

4.00

141.64

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

169

229

7.46

117.34

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

406

1238

3.35

107.31

1.2

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

702

2940

2.46

102.73

1.2

1.4

576.02

523.58

mg/l

1.75

679

2794

(40768804) Tissue Pathology biopsy report

6425

51381

1.45

98.94

2.2

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

603

2392

2.59

98.93

1.2

1.4

—

(40761536) Microorganisms panel - Urine sediment

400

10725

0.36

96.16

4.2

4.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

622

2577

2.48

93.07

1.2

1.3

3.55

3.76

mmol/l

6.25

575

2428

(3019225) pH of Specimen

1941

12193

1.68

89.07

3.6

4.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

104

9.68

85.91

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

12608

116769

1.61

78.47

11.3

13.1

82.39

81.84

ml/min/173m2

2.64

10322

96771

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

469

10446

0.43

71.98

2.8

3.8

1.23

mmol/l

0.63

424

9121

(3029937) Albumin [Presence] in Urine by Test strip

2365

32863

0.66

68.42

3.8

4.1

0.00

estimate

3.64

548

11251

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

651

12627

0.49

67.97

2.5

3.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8921

78199

1.37

67.90

3.1

2.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

263

833

3.20

65.36

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

322

1146

2.85

65.21

1.3

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

275

913

3.05

63.10

1.1

1.2

53.43

39.83

mg/l

2.48

262

750

(3014051) Protein [Presence] in Urine by Test strip

633

3155

2.05

60.31

2.8

2.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

269

906

3.01

60.21

1.2

1.3

1.93

2.08

mmol/l

1.89

245

850

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

264

887

3.01

59.34

1.1

330.14

255.47

mg/l

4.19

251

766

(3041096) Erythrocytes [Presence] in Urine by Automated

2451

32926

0.69

57.10

2.7

3.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

14157

137236

2.36

54.58

18.8

20.8

136.38

135.42

g/l

15.77

13931

135485

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3767

46846

0.74

54.16

3.3

3.8

—

(3010813) Leukocytes [#/volume] in Blood

14153

137208

2.34

54.08

18.8

20.7

6.36

6.67

e9/l

43.18

13696

133424

(3009542) Hematocrit [Volume Fraction] of Blood

14138

137003

2.30

54.08

18.8

20.8

40.92

40.42

0.80

13704

128466

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3777

29745

1.36

54.04

2.2

2.3

—

(3024731) MCV [Entitic volume]

14151

137189

2.33

53.93

18.7

20.6

91.11

90.98

3.04

13914

135441

(3026361) Erythrocytes [#/volume] in Blood

14152

137203

2.33

53.92

18.8

20.7

4.51

4.50

e12/l

5.44

13654

133471

(3035941) MCH [Entitic mass]

14148

137173

2.32

53.47

18.7

20.6

30.37

30.29

6.39

13912

135427

(3007461) Platelets [#/volume] in Blood

14143

137107

2.30

53.43

18.8

20.7

248.07

253.68

e9/l

23.94

13728

133737

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

194

608

3.22

49.16

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13684

131663

1.70

46.48

10.5

10.6

25.74

26.35

u/l

3.27

13110

127254

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

186

594

3.16

45.71

1.2

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

191

630

3.06

44.43

1.1

—

(3047181) Lactate [Moles/volume] in Blood

117

3960

0.29

43.63

3.2

6.0

1.20

1.30

mmol/l

0.78

109

3487

(3035320) C reactive protein [Mass/volume] in Body fluid

231

863

2.70

42.77

2.6

2.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

499

2609

1.95

41.44

1.3

1.5

505.62

2768.73

e6/l

0.93

379

2127

(3013707) Erythrocyte sedimentation rate by Westergren method

10046

92266

1.29

40.95

4.4

4.1

10.49

12.09

mm/h

31.16

9179

85646

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

195

4974

0.38

40.79

3.2

5.2

1.52

1.66

1.14

187

4636

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

496

2609

1.93

40.47

1.2

1.4

38.18

31.08

e6/l

0.27

364

2006

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2048

15211

1.40

40.32

5.2

6.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

193

4902

0.39

39.97

3.3

5.3

0.87

0.90

0.29

187

4573

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

150

5.22

38.41

1.2

1.3

79.00

50.97

5.64

(3033658) Prothrombin time (PT) actual/Normal

3840

31564

1.29

38.00

3.4

4.0

93.04

91.45

3.80

3740

30755

(3010421) pH of Blood

3305

0.28

37.23

3.3

3.9

7.42

0.05

3019

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1984

26014

0.73

37.01

1.5

1.7

32962029.01

33321441.76

pmol/l

0.01

1614

21632

(3008152) Bicarbonate [Moles/volume] in Arterial blood

399

7515

0.52

36.97

7.2

7.3

24.85

24.62

mmol/l

0.84

392

7134

(40758558) Short blood count panel - Blood

3823

31520

1.29

36.69

7.1

7.0

—

(3006462) Nitrate [Presence] in Urine

164

559

2.96

36.10

4.2

3.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13003

124598

1.42

35.13

5.0

4.9

2.85

2.79

mmol/l

10.24

11816

115277

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12900

123485

1.41

34.62

12.4

14.0

21.77

23.13

mg/l

4.40

9838

97676

(3027315) Oxygen [Partial pressure] in Blood

2879

0.26

34.31

3.6

4.0

8.81

8.67

kpa

0.35

2821

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2635

20829

1.32

34.20

1.3

10.66

12.64

u/ml

0.72

835

8129

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2776

22121

1.32

33.99

1.3

34.36

35.27

iu/ml

0.08

812

7115

(3013290) Carbon dioxide [Partial pressure] in Blood

2858

0.27

33.88

3.6

3.9

4.99

5.00

kpa

0.10

2801

(3018010) Neutrophils/100 leukocytes in Blood

6679

59157

1.24

33.88

6.1

6.0

55.68

56.99

17.46

6197

55470

(3017181) Myelocytes/100 leukocytes in Blood

680

10811

0.61

33.86

4.1

0.94

0.01

260

3662

(3012501) Base excess in Blood by calculation

2856

0.27

33.84

3.6

3.9

1.86

2.49

mmol/l

2.20

1961

(3019060) Gas panel - Arterial blood

446

7917

0.55

33.83

4.1

5.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12723

121622

1.38

33.43

4.5

4.4

1.53

1.48

mmol/l

33.53

11555

112542

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2468

19400

1.33

33.20

3.2

3.0

0.71

0.75

ug/l

1.41

1623

12904

(3025159) Blasts/100 leukocytes in Blood

602

9783

0.60

32.76

4.1

4.2

0.04

0.35

3.31

185

2676

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12796

122501

1.38

32.71

4.5

4.4

4.79

4.71

mmol/l

16.07

11657

113944

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

6.48

32.70

1.1

1.2

7.00

26.05

1.85

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

311

1502

2.09

32.29

1.8

2.1

23.20

26.35

mg/l

0.44

429

(40768443) Skin Pathology biopsy report

857

5591

1.57

32.21

1.2

—

(40761511) CBC panel - Blood by Automated count

13309

128348

1.45

32.02

10.9

13.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12334

117501

1.33

31.83

4.0

1.23

1.30

mmol/l

28.44

11074

107903

(3021440) Promyelocytes/100 leukocytes in Blood

653

10294

0.62

31.26

4.1

4.2

0.12

0.11

0.10

236

3159

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2598

20724

1.31

31.24

2.7

0.86

1.30

e6/l

2.41

1409

11774

(3037522) Nuclear Ab [Titer] in Serum

2230

17420

1.33

31.12

1.4

1.3

476.17

541.41

titre

0.99

460

3696

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

103

293

3.53

30.58

1.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

6728

60057

1.22

30.31

6.3

29.50

28.18

20.26

6234

56386

(3022096) Basophils/100 leukocytes in Blood

6351

56360

1.23

30.30

6.4

6.2

0.73

0.69

11.15

5832

52566

(3002179) Metamyelocytes/100 leukocytes in Blood

625

9878

0.62

30.21

3.9

4.0

0.70

0.72

0.06

240

3180

(3019069) Monocytes/100 leukocytes in Blood

6567

58498

1.22

30.12

6.5

8.58

8.54

0.44

6071

54796

(3006504) Eosinophils/100 leukocytes in Blood

6533

58173

1.22

30.05

6.3

6.2

2.92

2.86

1.47

6026

54385

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5654

49657

1.23

29.59

2.0

1.9

101.07

96.72

pmol/l

7.60

2646

25680

(3013650) Neutrophils [#/volume] in Blood by Automated count

7905

71850

1.22

29.36

8.5

9.4

3.75

4.06

e9/l

25.78

6702

62814

(40767503) Oxygen content in Capillary blood by calculation

2648

0.30

28.65

2.3

2.5

16.07

16.36

0.31

1343

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

288

3.45

28.44

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

310

1573

1.99

28.16

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

100

295

3.41

28.11

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

296

3.33

26.57

1.1

—

(3001604) Monocytes [#/volume] in Blood

6882

62103

1.21

26.13

6.1

6.0

0.55

0.58

e9/l

26.10

5802

53817

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

530

3245

1.66

25.88

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11992

114458

1.28

25.84

5.0

4.8

1.92

2.12

mu/l

2.45

10727

105334

(3006315) Basophils [#/volume] in Blood

6892

62251

1.20

25.75

6.1

6.0

0.04

e9/l

0.50

5812

53894

(3019198) Lymphocytes [#/volume] in Blood

7048

63856

1.20

25.28

6.1

6.0

1.91

1.94

e9/l

0.65

6072

56566

(3011397) Hemoglobin [Presence] in Urine by Test strip

3384

28511

1.24

25.24

3.2

3.6

—

(3013115) Eosinophils [#/volume] in Blood

7096

64350

1.20

25.15

6.3

6.2

0.19

e9/l

2.93

6094

56527

(1616796) Gas panel - Central venous blood

101

2751

0.36

24.47

3.1

3.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3253

38263

0.81

24.32

3.6

3.8

7.05

8.90

mg/mmol

0.71

1847

23753

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12466

119783

1.29

23.97

4.6

5.76

5.92

mmol/l

52.75

11157

109763

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

155

637

2.45

23.80

1.4

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2891

24099

1.25

23.47

1.4

1.5

2.32

2.41

g/l

1.51

1515

14578

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

149

4.17

23.44

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

275

3.25

23.32

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

4478

39085

1.21

23.31

2.1

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2348

19161

1.27

22.82

2.8

2.9

2.29

2.77

e6/l

1.49

1169

10269

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1413

10788

1.34

22.55

1.8

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13489

131277

1.40

22.32

14.1

16.3

74.05

75.74

umol/l

15.24

13483

131234

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

544

3483

1.58

22.16

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

2579

0.38

22.04

3.6

3.4

3.77

4.04

e9/l

0.87

2574

(3013247) Albumin in CSF/Albumin in Serum or Plasma

221

3.45

21.94

1.1

1.0

8.71

6.68

mg/g

1.17

209

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

519

3301

1.59

21.75

1.3

6.16

6.76

u/ml

0.08

547

(40760892) CBC W Ordered Manual Differential panel - Blood

6457

58525

1.19

21.67

6.2

6.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

626

4162

1.53

21.56

1.9

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

511

3255

1.59

21.29

1.2

1.3

1.73

6.86

u/ml

2.24

357

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8846

82468

1.19

21.03

3.0

3.1

41.99

47.90

u/l

9.48

8144

77004

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

153

3.93

20.98

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

552

3594

1.56

20.92

1.3

32.39

38.98

u/ml

0.20

227

(3037467) Urinalysis macro (dipstick) panel - Urine

9062

84700

1.19

20.75

4.2

4.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

13105

127187

1.32

20.26

13.6

16.0

3.95

3.96

mmol/l

7.37

12682

123954

(3019550) Sodium [Moles/volume] in Serum or Plasma

13068

126839

1.31

19.71

13.4

15.9

139.90

139.70

mmol/l

20.14

12688

123844

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

433

2707

1.62

19.52

1.2

1.14

4.78

u/ml

2.61

206

(3021901) Oxygen saturation in Capillary blood

2155

0.36

19.29

2.3

3.0

—

(3048689) Calprotectin [Mass/mass] in Stool

1896

15366

1.27

19.23

2.2

2.3

115.93

131.73

ug/g

1.24

1413

12110

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

516

3377

1.55

19.13

1.5

1.4

18.08

14.48

iu/ml

0.22

(36660697) Celiac disease serology panel - Serum

1285

9941

1.32

18.60

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

157

724

2.18

18.57

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6122

55755

1.17

18.15

4.8

6.0

1.22

1.21

mmol/l

21.47

5405

50935

(3030981) Hyaline casts [#/volume] in Urine by Automated count

406

6277

0.64

17.63

1.8

2.7

0.28

e6/l

0.02

389

6106

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

183

914

2.02

17.57

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

182

912

2.01

17.32

1.2

—

(1761868) Lipid panel - Serum or Plasma

3915

44173

0.84

17.32

2.4

2.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

351

5584

0.62

17.30

2.6

3.5

25.20

25.27

mmol/l

0.19

345

5411

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

181

909

2.00

17.12

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

181

909

2.00

17.12

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1606

0.31

17.09

1.8

91.05

89.86

0.74

1581

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1456

11582

1.29

17.06

2.3

2.5

35.59

50.28

u/l

1.24

1239

9911

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

912

2.00

16.97

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

209

1109

1.90

16.84

1.3

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

301

1792

1.69

16.49

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

179

908

1.98

16.48

1.2

—

(3012516) Albumin [Mass/volume] in Urine

3187

36473

0.84

16.43

3.1

3.3

248.90

424.87

mg/l

1.72

1823

22833

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

951

7177

1.35

16.28

1.5

1.4

—

(3045414) Leukocytes [Presence] in Urine

767

5603

1.39

16.12

2.0

1.8

—

(3003396) Base excess in Arterial blood by calculation

1068

13722

0.76

15.94

6.6

7.3

0.62

1.08

mmol/l

4.61

921

10967

(3047007) Chlamydophila sp Ab [Presence] in Serum

293

1763

1.68

15.45

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

8584

80725

1.16

15.45

4.2

4.4

2084.50

1516.40

e6/l

0.16

1061

(1761482) Bacteria [#/volume] in Urine by Culture

153

2958

0.51

15.42

4.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

122

3.78

15.32

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

272

1612

1.70

15.19

1.5

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

234

1333

1.77

15.05

1.7

1.5

28.67

29.59

iu/ml

0.06

(3025468) Yersinia sp identified in Specimen by Organism specific culture

268

1588

1.70

14.98

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11765

113505

1.19

14.87

5.3

5.7

38.33

39.63

mmol/mol

65.58

10576

105320

(3022145) Colonoscopy Study observation

1728

14248

1.24

14.84

1.3

—

(3016502) Oxygen saturation in Arterial blood

950

12284

0.76

14.82

7.0

7.7

95.88

95.75

0.23

939

11809

(3005988) Vibrio sp identified in Specimen by Organism specific culture

268

1593

1.70

14.82

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2560

21969

1.20

14.76

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

269

1605

1.69

14.67

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

267

1591

1.69

14.63

1.5

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1084

13749

0.77

14.61

6.5

7.3

5.09

5.10

kpa

0.06

1047

13134

(3027801) Oxygen [Partial pressure] in Arterial blood

1084

13741

0.77

14.54

6.5

7.3

13.37

12.49

kpa

5.21

1049

13118

(3019150) Specific gravity of Urine by Refractometry

2259

26417

0.83

14.49

3.6

4.0

1.02

kg/l

0.10

345

3982

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

273

1642

1.68

14.45

1.5

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

506

3501

1.46

14.42

2.7

2.2

38.77

37.84

g/l

2.98

428

3069

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10023

95553

1.16

14.29

7.2

7.7

74.56

77.99

u/l

16.54

9306

90316

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

461

3141

1.48

14.21

2.7

2.4

0.00

g/l

0.92

407

2864

(3000012) Reticulocyte production index

1690

0.39

14.12

2.3

2.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

213

3640

0.58

14.07

1.4

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

877

11379

0.76

14.00

7.4

8.1

122.30

121.26

g/l

0.88

870

11049

(3009508) Creatinine [Moles/volume] in Urine

3465

38974

0.85

14.00

3.0

3.2

7.65

7.47

mmol/l

1.53

2774

32958

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

615

4438

1.40

13.92

1.6

1.7

3.25

3.91

mg/l

0.98

442

3251

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

504

3525

1.45

13.59

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3796

33872

1.16

13.57

5.5

4.9

2.44

2.99

ug/l

1.69

3340

30478

(42529406) Shigella sp [Presence] in Stool by Culture

509

3568

1.44

13.56

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1477

12091

1.25

13.49

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3100

27240

1.18

13.44

1.7

1.8

1.00

1.16

mg/l

2.01

2265

20816

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

486

3384

1.45

13.42

2.8

2.3

0.02

0.03

g/l

0.53

430

3097

(3014765) Yersinia sp identified in Stool by Organism specific culture

507

3559

1.44

13.41

1.1

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

539

3831

1.42

13.31

2.7

2.4

0.95

0.87

g/l

0.19

456

3304

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

761

10002

0.75

13.30

2.1

2.8

141.80

178.40

ng/l

3.55

685

9095

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

299

1885

1.60

13.17

1.1

10.74

11.75

au/ml

0.12

105

(3026782) Osmolality of Urine

2069

24173

0.83

12.95

2.5

2.9

552.50

536.89

mosm/kgh2o

2.53

1655

20780

(3038026) Centromere Ab [Units/volume] in Serum

186

1037

1.80

12.93

1.2

38.39

49.73

u/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

448

3095

1.46

12.90

2.8

2.4

0.00

g/l

-0.00

405

2852

(3000034) Microalbumin [Mass/volume] in Urine

1162

0.30

12.86

3.2

3.0

80.88

51.22

mg/l

0.20

842

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

210

1219

1.73

12.73

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

614

2.04

12.71

1.1

4.79

7.06

u/ml

0.52

104

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

637

4704

1.37

12.57

1.6

—

(3044889) 12 lead EKG panel

8247

86970

0.88

12.40

3.4

3.7

—

(3002256) Pathology report gross observation

1936

16439

1.21

12.32

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

473

6612

0.71

12.26

8.5

9.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1018

8064

1.28

12.26

2.2

2.1

13.18

12.45

nmol/l

1.92

905

7200

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

174

967

1.81

12.26

1.2

2.20

7.38

u/ml

1.13

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

657

1.99

12.23

1.1

1.14

1.08

u/l

0.36

299

(3028679) Herpes simplex virus Ab [Presence] in Serum

121

596

2.04

12.23

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

871

6770

1.30

12.13

1.5

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

179

1011

1.78

11.96

1.2

77.00

76.61

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

3.42

11.88

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

125

3.37

11.87

1.1

—

(3013512) EKG study

3947

35608

1.15

11.81

3.9

3.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

179

1015

1.77

11.81

1.2

14.03

45.62

u/ml

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1560

0.42

11.75

2.4

2.1

33.30

32.78

0.58

1546

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5613

51861

1.13

11.69

2.2

2.3

79.49

1826.72

nmol/l

0.50

4811

46875

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

127

3.31

11.58

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

123

3.34

11.45

1.1

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

540

3944

1.38

11.43

1.5

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

631

4742

1.35

11.15

3.0

3.9

24.93

24.87

mmol/l

0.23

588

4388

(3022621) pH of Urine by Test strip

992

7933

1.27

11.06

2.8

2.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

215

1309

1.65

10.98

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

136

726

1.88

10.94

1.7

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1164

9503

1.24

10.85

2.6

2.8

10.57

10.46

g/l

0.35

1092

8714

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

141

766

1.85

10.75

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3098

27643

1.15

10.65

1.3

1.77

u/ml

0.00

616

7434

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

221

1373

1.62

10.44

1.5

1.8

11760.00

1150.00

titre

—

(3021589) Normoblasts [#/volume] in Blood

5106

55062

0.89

10.18

8.0

9.7

0.00

e9/l

2.49

3886

45211

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

380

2678

1.43

9.94

1.2

36.69

44.35

u/ml

0.36

273

(3017732) Neutrophils [#/volume] in Blood

1065

8702

1.24

9.85

2.5

2.9

4.37

4.84

e9/l

0.63

727

7041

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1304

10888

1.22

9.80

1.9

—

(3049717) Cytology report of Urine Cyto stain

570

4305

1.34

9.78

2.7

2.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

799

6320

1.28

9.76

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

10360

107148

0.88

9.73

15.0

16.7

14.87

14.99

1.00

10231

105363

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3015

27006

1.15

9.69

4.2

21.74

21.81

0.10

1452

13023

(3004119) Hemoglobin [Mass/volume] in Venous blood

537

7086

0.75

9.66

2.3

3.5

132.65

129.03

g/l

4.07

528

6908

(3019977) pH of Arterial blood

667

0.21

9.62

2.1

2.8

7.43

7.42

—

231

(3026008) Bacteria identified in Urine by Culture

3382

37306

0.88

9.59

2.7

3.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

563

4260

1.33

9.55

2.6

2.4

2.91

2.92

g/l

0.13

488

3837

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1512

0.47

9.47

1.4

1.5

—

(1002224) Polysomnography panel

652

5044

1.31

9.46

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

591

4514

1.32

9.40

1.7

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

288

4168

0.68

9.14

1.5

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1347

15877

0.83

9.05

4.5

6.0

1.01

1.04

mmol/l

3.32

1237

14822

(4146454) Self-monitoring of blood glucose

203

1282

1.59

9.03

2.9

2.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

137

780

1.76

9.03

1.1

8.42

9.18

iu/ml

0.13

183

(46235355) HIV 1 and 2 tests - Meaningful Use set

2318

20476

1.16

8.99

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

685

5380

1.29

8.87

1.9

2.0

41.92

39.12

u/l

3.06

593

4771

(3026493) Urate [Moles/volume] in Serum or Plasma

3576

32552

1.13

8.86

2.4

2.6

5172.15

4084.24

umol/l

0.78

3035

28552

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3765

41091

0.89

8.84

2.9

3.3

31.37

34.05

u/l

2.73

3581

38952

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

192

1208

1.60

8.70

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

119

658

1.82

8.67

1.3

1.5

5.94

7.90

ug/l

2.30

113

587

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

191

2966

0.64

8.63

2.2

2.3

100.88

104.12

ug/min

0.04

107

1779

(3021960) Folate [Moles/volume] in Serum or Plasma

3069

27728

1.14

8.52

1.5

21.90

20.57

nmol/l

5.00

2464

23736

(3041354) Potassium [Moles/volume] in Venous blood

1395

0.49

8.42

1.8

2.3

4.05

4.04

mmol/l

0.04

1381

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

113

1982

0.57

8.41

1.4

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

1394

0.49

8.40

1.8

2.3

106.07

105.47

mmol/l

0.49

1380

(3040151) Glucose [Moles/volume] in Capillary blood

1337

0.48

8.36

1.8

11.9

7.05

7.57

mmol/l

0.48

1113

(3020779) Urea [Moles/volume] in Serum or Plasma

870

10618

0.81

8.33

5.4

7.8

8.15

9.50

mmol/l

9.04

817

10149

(3002032) Base excess in Venous blood by calculation

890

10836

0.81

8.33

3.1

4.1

1.62

1.95

mmol/l

2.30

786

9221

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

511

3899

1.32

8.23

1.7

1.17

1.18

g/l

0.68

476

3701

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

148

2408

0.61

8.22

2.4

3.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

893

10849

0.81

8.18

3.1

4.1

5.82

5.83

kpa

0.18

871

10533

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

794

6414

1.25

8.17

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

125

715

1.75

8.16

1.4

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

582

4529

1.30

8.13

2.6

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

582

4532

1.30

8.09

2.6

2.3

7.06

7.40

g/l

4.90

506

4106

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1370

0.49

8.01

1.8

2.3

—

(3008898) HLA-B27 [Presence]

539

4164

1.31

7.95

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

542

4191

1.30

7.95

1.4

1.6

527.50

276.76

titre

0.51

182

(36304419) Bacteria [Presence] in Urine

3593

32905

1.12

7.90

3.0

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9983

96441

1.11

7.89

4.1

14.64

14.76

pmol/l

5.56

8863

88095

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

369

0.19

7.86

1.1

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

369

0.19

7.86

1.1

2.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

544

4219

1.30

7.81

2.6

2.3

9.99

10.14

g/l

0.37

468

3763

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

958

0.41

7.80

1.3

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

578

4521

1.29

7.77

2.6

2.3

3.59

3.68

g/l

0.75

502

4096

(3035350) Ketones [Presence] in Urine by Test strip

5713

60644

0.90

7.76

3.2

3.6

0.00

estimate

4.28

569

12257

(3000475) Leukocytes [#/volume] in Synovial fluid

406

3023

1.35

7.75

1.6

11019.13

14032.59

e6/l

1.01

296

2181

(40762814) Titanium [Mass/volume] in Blood

209

2.40

7.71

2.5

2.3

3.08

3.78

ug/l

0.78

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

378

2.02

7.66

2.7

3.1

—

(3023368) Bacteria identified in Blood by Culture

2905

31912

0.89

7.36

3.6

4.3

—

(40761535) Cells panel - Urine sediment

1165

9894

1.19

7.31

3.2

3.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

490

3786

1.30

7.26

1.8

1.7

0.23

g/l

0.90

453

3581

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

298

2135

1.40

7.23

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1139

9668

1.19

7.20

1.6

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

298

2139

1.40

7.16

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

169

2582

0.65

7.16

3.4

3.5

29.76

26.55

mg/l

0.21

1601

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4002

37039

1.11

7.15

2.0

2.2

162.57

206.67

u/l

4.91

3744

34694

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

104

1781

0.58

7.15

1.8

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

243

1685

1.45

7.08

1.1

2.48

3.60

u/ml

1.13

792

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

298

2144

1.40

7.07

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

298

2146

1.40

7.03

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

184

2750

0.66

7.01

1.8

2.2

132.51

129.58

g/l

0.78

1958

(3025130) Human papilloma virus identified in Specimen

238

1653

1.45

6.88

1.6

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

270

1920

1.41

6.86

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

410

3116

1.32

6.86

1.7

45.20

41.23

nmol/l

2.63

395

3011

(3009445) Proteinase 3 Ab [Units/volume] in Serum

663

5358

1.25

6.85

1.5

1.6

11.92

15.15

u/ml

0.28

146

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

121

723

1.68

6.83

1.1

3.91

7.75

nmol/l

0.58

137

(3039162) Centromere protein B Ab [Units/volume] in Serum

233

1617

1.45

6.78

1.2

1.3

66.53

59.92

u/ml

—

125

(3022217) INR in Platelet poor plasma by Coagulation assay

5288

56055

0.91

6.61

13.1

13.9

1.37

1.23

inr

0.39

862

16566

(3004775) Volume in Urine collected for unspecified duration

983

0.47

6.51

2.7

2.3

659.83

656.70

0.02

689

(40768797) Stomach Pathology biopsy report

1973

17604

1.14

6.51

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

772

0.40

6.49

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

345

0.23

6.44

1.3

1.4

1.75

2.58

—

293

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1655

0.59

6.43

1.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.13

6.42

1.5

1.4

11.70

36.17

2.92

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

354

4660

0.75

6.37

1.9

2.0

1.26

2.27

ug/l

2.30

313

4152

(3003434) Protein [Mass/volume] in Pleural fluid

1498

0.57

6.36

1.5

33.93

33.53

g/l

0.11

1363

(3003338) MCHC [Mass/volume]

10763

104782

1.11

6.33

16.3

18.0

332.44

332.30

g/l

0.95

10697

104131

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

614

4966

1.25

6.32

1.9

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

609

7489

0.80

6.30

6.6

7.3

24.99

24.80

mmol/l

0.77

609

7430

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

777

6448

1.22

6.27

2.5

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

685

0.38

6.21

1.4

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

106

1737

0.61

6.19

1.3

6.80

7.39

mmol/l

1.50

1542

(3006576) Bicarbonate [Moles/volume] in Blood

434

0.23

6.10

7.1

6.3

26.67

25.09

mmol/l

—

394

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

311

2312

1.35

6.09

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

690

0.39

6.03

1.4

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

296

3960

0.74

5.99

2.7

3.2

0.36

0.35

u/ml

0.18

158

2285

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

728

0.41

5.94

16.4

18.6

1332.90

2737.57

nmol/l

0.55

705

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1119

12930

0.85

5.90

1.7

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

167

2448

0.68

5.84

1.8

1.9

0.82

nmol/l

0.00

138

2051

(3041806) Other cells [#/volume] in Blood by Manual count

325

1.94

5.83

1.6

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1615

14329

1.14

5.78

2.7

6.76

8.31

umol/l

3.17

1420

12393

(3004716) Salmonella sp identified in Stool by Organism specific culture

737

6141

1.21

5.73

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

228

1630

1.41

5.70

1.1

—

(3000494) Fungus identified in Specimen by Culture

1671

14875

1.14

5.69

1.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

468

3716

1.27

5.69

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

264

1940

1.37

5.61

1.7

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

344

1.89

5.59

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4438

41682

1.09

5.59

3.1

3.5

2.37

2.36

mmol/l

6.71

3598

36783

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

431

3397

1.28

5.57

2.0

2.1

11.98

11.10

mg/l

0.89

393

3173

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

128

822

1.56

5.49

1.3

154.00

178.18

pmol/l

0.95

128

822

(3029634) Reagin Ab [Titer] in Serum by VDRL

229

1652

1.39

5.46

1.8

2.0

3.83

6.19

titre

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

147

2.38

5.44

1.0

0.30

0.24

u/ml

0.10

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

153

1035

1.48

5.18

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

302

0.26

5.18

1.3

1.4

41.97

22.38

—

270

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

621

5143

1.22

5.18

1.1

20.26

9.64

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

250

1847

1.36

5.17

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

2344

25602

0.90

5.15

2.4

2.6

4.77

5.74

e6/l

2.79

2014

22973

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

102

1610

0.63

5.15

1.4

—

(3005033) Fetal Nuchal fold Thickness US

238

1747

1.37

5.13

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

122

1851

0.66

5.13

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

245

1809

1.36

5.09

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

385

1.80

5.07

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

238

1751

1.37

5.06

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1363

0.61

4.98

1.5

1.6

—

(3004451) EKG impression Narrative

589

0.41

4.96

1.5

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

105

2.57

4.95

1.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

6.88

4.94

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

248

1847

1.35

4.89

1.1

—

(3035880) pH of Pleural fluid

599

0.42

4.88

1.1

1.3

—

(3020891) Body temperature

378

4752

0.79

4.84

4.8

4.9

—

(3030467) Casts [#/volume] in Urine by Automated count

3607

33745

1.09

4.84

3.1

0.29

0.41

e6/l

3.87

2537

25614

(3013139) Helicobacter pylori Ag [Presence] in Stool

984

8549

1.16

4.76

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

154

2198

0.70

4.74

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.27

4.74

1.0

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

323

2513

1.29

4.70

1.9

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

755

8832

0.85

4.67

2.4

3.5

4.64

4.61

kpa

0.13

736

8543

(3035947) Staphylolysin Ab [Units/volume] in Serum

562

1.62

4.66

1.1

3.86

4.00

iu/ml

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6408

61431

1.08

4.64

5.3

6.8

1.22

mmol/l

20.38

5682

52083

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

126

842

1.50

4.58

2.4

2.6

0.23

0.24

e9/l

0.15

111

729

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

348

1.78

4.51

1.0

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1836

20157

0.90

4.41

2.8

3.5

0.83

0.82

mmol/l

6.03

1699

18900

(3044242) Glucose [Moles/volume] in Arterial blood

573

0.44

4.41

1.8

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

326

2562

1.28

4.41

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

121

1776

0.68

4.37

4.2

5.1

363.12

368.78

umol/l

0.16

1535

(3004446) Plasmodium sp identified in Blood by Light microscopy

106

2.46

4.36

2.2

2.6

—

(3022313) Gas panel - Capillary blood

641

5420

1.19

4.34

3.0

3.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

806

0.53

4.26

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

5820

60715

0.93

4.25

4.5

4.9

0.00

estimate

0.32

547

11626

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

113

1669

0.67

4.23

4.8

6.7

10.38

11.60

mg/l

2.50

102

1533

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

124

841

1.48

4.23

1.4

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1170

0.61

4.21

1.5

33.17

31.64

0.15

688

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

123

834

1.48

4.21

1.4

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1312

14640

0.89

4.19

1.6

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1265

11290

1.13

4.17

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

190

1400

1.36

4.09

1.4

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

127

872

1.46

4.09

2.3

2.6

468.52

515.77

e6/l

0.66

110

733

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3698

39184

0.92

4.06

2.4

2.6

61.72

65.24

u/l

0.46

3309

36159

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

223

2921

0.76

4.03

1.7

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

113

761

1.49

4.01

1.3

1.5

5.88

6.13

u/l

0.20

644

(3042631) Mycobacterium sp identified in Specimen

114

1662

0.68

4.01

2.7

2.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1325

0.65

3.99

1.5

3492.13

2834.87

e6/l

0.15

960

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

156

2150

0.72

3.98

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

722

0.53

3.96

1.3

5.66

5.85

mmol/l

0.75

677

(3045788) Cell count panel - Pleural fluid

1028

0.60

3.96

1.6

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1149

12879

0.88

3.96

1.6

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

261

3341

0.78

3.96

3.0

3.6

1.28

1.52

mg/l

7.85

241

3070

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

467

3873

1.21

3.93

1.5

1.6

0.34

6.51

iu/ml

0.88

100

870

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

242

1861

1.31

3.91

1.2

3.20

3.92

u/ml

0.86

113

818

(3018095) Leukocytes [#/volume] in Urine

4529

43078

1.07

3.87

3.6

3.7

66.38

93.20

e6/l

2.29

2860

30349

(3008757) Leukocyte morphology finding [Identifier] in Blood

181

1337

1.36

3.86

3.7

3.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1749

19119

0.90

3.86

2.2

2.5

14.55

13.16

umol/l

13.02

1639

17824

(3045683) HLA typing for celiac disease panel - Blood or Tissue

111

752

1.48

3.85

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

440

3637

1.22

3.84

1.2

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

489

1.60

3.84

2.0

1.9

—

(40757373) Influenza virus identified in Isolate

244

0.29

3.82

1.0

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

218

2841

0.76

3.81

1.8

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5503

52726

1.07

3.81

2.8

2.9

114.75

127.05

ug/l

2.99

5021

48930

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

586

1.54

3.77

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

586

1.54

3.77

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.18

3.77

1.0

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

202

1.93

3.70

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

404

3326

1.22

3.69

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

175

2.00

3.67

1.7

1.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

289

1.77

3.67

1.1

1.2

—

962.50

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

138

985

1.40

3.65

1.1

299.18

290.74

mg/l

0.58

124

881

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

291

1.76

3.59

1.2

254.26

316.69

pmol/l

0.83

209

(3020191) Ethanol [Moles/volume] in Serum or Plasma

988

0.62

3.58

2.0

1.4

1.12

1.32

promille

0.44

754

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

124

878

1.42

3.45

1.3

1.4

10.84

12.49

umol/l

2.86

118

831

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

342

2792

1.23

3.42

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

149

2012

0.74

3.39

1.4

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

289

1.73

3.39

1.1

1.3

—

(21494755) Public health laboratory ask at order entry panel

1276

11544

1.12

3.37

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.44

3.37

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1508

16493

0.90

3.37

2.3

2.6

24.62

22.60

6.81

1386

14042

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

1719

0.72

3.35

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2397

22368

1.09

3.32

2.8

3.1

2.44

2.45

mmol/l

5.62

2058

19685

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

223

0.31

3.30

9.7

6.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

197

2545

0.77

3.28

3.4

2.8

31.61

34.02

umol/l

0.76

178

2304

(21494434) Karyotype in Bone marrow

137

997

1.38

3.27

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

764

6712

1.15

3.26

2.0

1.9

—

(3021788) Differential panel - Synovial fluid

286

2304

1.25

3.25

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

411

0.44

3.25

3.1

3.5

44.97

53.32

0.82

397

(3022689) Creatine [Moles/volume] in Urine

382

0.42

3.23

1.6

1.5

—

(3017569) Oxygen content in Arterial blood

556

0.52

3.19

2.2

2.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1188

0.67

3.19

1.5

34973.65

59719.70

e6/l

0.91

696

(3042936) Bacteria identified in Isolate by Culture

1592

17311

0.91

3.16

1.7

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

442

3734

1.19

3.13

2.6

3.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

175

1334

1.32

3.10

1.1

98.74

95.58

0.95

162

1252

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

181

0.28

3.09

9.2

10.6

5.24

5.36

mmol/l

—

181

(3013005) Retinol [Moles/volume] in Serum or Plasma

525

1.51

3.09

1.6

1.7

1.99

1.97

umol/l

0.12

494

(3024891) Influenza virus A+B Ag [Presence] in Specimen

370

3081

1.21

3.08

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

574

0.54

3.06

3.7

3.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.38

3.05

1.1

—

(3024316) Viscosity of Plasma

2.68

3.05

1.1

1.6

1.51

1.59

mpas

—

(3052592) Norovirus Ag [Presence] in Stool

228

0.35

3.03

1.0

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

512

1.51

3.01

2.2

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

512

1.51

3.01

2.2

2.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

103

726

1.42

2.99

1.2

1.3

52.86

69.84

titre

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.55

2.98

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

100

2.20

2.98

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

394

1.58

2.97

1.4

1.2

107.89

111.40

0.52

344

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1626

17610

0.91

2.97

2.2

2.5

2.37

2.35

g/l

1.11

1498

16310

(3010144) Erythrocytes [#/volume] in Synovial fluid

155

1172

1.33

2.93

1.4

46621.00

114268.31

e6/l

1.53

110

804

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

309

0.39

2.93

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

310

1.65

2.92

1.1

1.3

152.72

122.39

nmol/l

0.81

232

(3043410) Blood group antigens tested for on Red Blood Cells

322

0.40

2.90

1.5

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

240

0.37

2.90

7.1

2.1

1.18

mmol/l

—

231

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

149

1124

1.33

2.87

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

542

1.48

2.87

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

272

2213

1.23

2.87

1.9

206.69

197.00

pmol/l

0.82

256

2080

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

954

8576

1.12

2.87

1.2

155.55

145.55

iu/ml

0.28

299

3268

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

105

750

1.40

2.85

1.2

1.3

20.00

301.18

titre

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

519

1.49

2.84

2.2

2.1

—

(3020650) Glucose [Presence] in Urine

317

0.41

2.81

2.8

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

316

0.41

2.79

6.5

7.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

2.78

0.0

3.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

207

2596

0.79

2.77

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

1150

0.69

2.74

1.6

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

301

1.63

2.72

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

111

2.07

2.72

1.0

1.1

—

(4035726) Immunohistochemistry procedure

1244

11388

1.10

2.67

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

568

1.45

2.66

2.3

1.9

132.91

147.98

1.02

531

(4200892) Spirometry reversibility

1027

9312

1.11

2.66

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

194

1536

1.27

2.64

1.1

—

(40768793) Breast Pathology biopsy report

357

3014

1.19

2.61

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

413

3531

1.17

2.61

2.7

2.5

178.45

190.43

2.21

389

3346

(3025577) Chromium [Mass/volume] in Blood

102

738

1.38

2.60

2.1

3.43

2.39

ug/l

0.86

620

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

388

0.49

2.60

2.0

1.9

2493.73

13513.08

e6/l

1.31

210

(3033799) Differential panel - Peritoneal fluid

388

0.49

2.60

2.2

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

392

1.53

2.59

1.1

90.70

88.11

0.20

174

(4094501) Cardiovascular stress test using bicycle ergometer

404

3451

1.18

2.58

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

278

2300

1.21

2.54

1.1

2.04

1.93

u/ml

0.06

138

1136

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

347

1.56

2.52

1.1

1.0

6.26

11.97

u/ml

1.65

192

(3026470) Cobalt [Mass/volume] in Blood

104

760

1.37

2.51

2.1

2.0

5.79

3.44

ug/l

1.06

696

(3022475) Manganese [Moles/volume] in Blood

2.16

2.50

1.1

1.3

—

(40768806) Pleura Pathology biopsy report

1187

0.71

2.50

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

214

2637

0.81

2.48

2.7

3.5

390.09

590.83

u/ml

0.23

190

2414

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

173

1.79

2.45

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

161

1259

1.28

2.45

3.5

3.3

55.29

56.60

0.35

136

1078

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

231

1884

1.23

2.44

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

233

1905

1.23

2.41

1.2

2.70

3.49

u/ml

0.44

633

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

222

1806

1.23

2.41

1.1

124.51

117.80

2.14

195

1623

(3009261) Glucose [Presence] in Urine by Test strip

5951

61306

0.95

2.39

3.2

3.7

0.00

estimate

3.25

536

11347

(3023487) Leukocytes [#/volume] in Peritoneal fluid

441

0.54

2.39

2.0

2.1

805.71

3943.81

e6/l

0.85

303

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

598

1.41

2.39

4.0

5.5

11766.80

6883.26

u/ml

—

104

(3051101) Glucose [Moles/volume] in Cord blood

193

0.36

2.38

3.0

6.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

678

0.63

2.38

1.5

1.29

1.23

nmol/l

0.13

534

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

321

1.56

2.36

1.6

1.5

0.40

0.39

ug/l

0.10

214

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

317

3740

0.84

2.34

2.3

2.2

4288.65

5029.02

u/l

0.22

122

1416

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

550

1.42

2.34

1.1

1605.56

1524.74

miu/ml

0.23

550

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

501

0.58

2.33

2.9

2.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

427

1.48

2.33

1.5

1.2

0.30

0.31

g/l

0.23

336

(40768446) Kidney Pathology biopsy report

513

0.58

2.32

1.3

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.04

2.31

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

253

2097

1.21

2.30

1.6

0.70

0.77

g/l

0.53

202

1581

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

947

0.70

2.30

1.6

—

(3005570) Glucose [Moles/volume] in Urine

1248

0.74

2.29

1.8

1.9

—

0.95

—

(3044941) Cell count panel - Synovial fluid

234

1927

1.22

2.28

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

101

1350

0.75

2.28

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

101

1350

0.75

2.28

1.6

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

230

1892

1.22

2.27

1.1

1.32

1.43

u/ml

0.08

110

932

(3015171) Extractable nuclear Ab [Units/volume] in Serum

579

5133

1.13

2.26

1.3

1.2

0.43

1.12

u/ml

1.88

478

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

168

1337

1.26

2.24

1.1

1.0

1.19

0.48

u/ml

0.49

380

(3042733) HLA Ab [Presence] in Serum

419

0.55

2.24

3.9

5.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

326

1.54

2.23

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

167

1330

1.26

2.22

1.6

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

250

2080

1.21

2.21

1.1

4.48

5.11

u/ml

0.34

129

1043

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

384

1.49

2.19

1.1

1.2

93.32

89.60

0.25

176

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

109

1431

0.76

2.18

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

213

0.42

2.17

4.6

2.0

1.19

1.20

mmol/l

—

208

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

268

0.45

2.15

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

101

1335

0.75

2.13

1.8

2.5

0.87

1.30

g/24h

1.38

664

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

131

1020

1.29

2.11

1.1

1.2

165.91

189.24

titre

0.15

184

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

197

1.68

2.11

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

197

1.68

2.11

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

197

1.68

2.11

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

168

2079

0.81

2.09

1.4

61.45

64.32

mmol/l

0.44

129

1667

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

107

812

1.32

2.08

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

137

1075

1.28

2.08

2.0

2.2

41.37

39.33

0.89

132

1054

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

155

1236

1.26

2.07

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1778

18899

0.93

2.06

1.7

1.8

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

161

1290

1.25

2.06

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

244

2041

1.20

2.06

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

593

5300

1.12

2.06

1.9

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1030

0.73

2.06

1.3

9.66

8.55

mmol/l

1.08

984

(3021879) Hepatitis B virus core Ab [Presence] in Serum

986

9051

1.10

2.06

1.4

—

(3028433) Virus identified in Specimen by Culture

431

1.44

2.05

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

275

0.47

2.03

6.5

6.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

107

817

1.31

2.01

1.1

—

(3011412) CD3 cells [#/volume] in Blood

155

1241

1.25

2.01

2.3

2.4

1.20

e9/l

0.02

139

1116

(3024869) Neuronal Ab [Presence] in Serum

247

1.58

2.00

1.1

—

(3020491) Glucose [Moles/volume] in Blood

115

889

1.30

1.98

1.4

1.8

6.31

6.71

mmol/l

1.51

620

(3020961) Endomysium IgA Ab [Titer] in Serum

646

5821

1.11

1.96

1.1

156.58

198.58

titre

0.32

147

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

682

1.34

1.95

2.1

2.2

98.79

98.26

0.05

632

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

290

2478

1.17

1.94

1.2

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

238

2001

1.19

1.92

1.1

0.76

1.14

u/ml

1.00

106

835

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

360

4130

0.87

1.92

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

266

1.54

1.91

1.1

103.33

79.36

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

685

1.33

1.90

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2213

21014

1.06

1.90

1.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.18

1.88

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.18

1.88

1.4

3.0

—

(3006270) Folate [Moles/volume] in Blood

124

976

1.27

1.87

1.2

382.38

364.04

nmol/l

0.46

117

833

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

388

3401

1.14

1.86

1.1

4.57

7.58

u/ml

0.91

417

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

101

775

1.31

1.86

1.3

1.4

1.62

1.56

g/l

1.37

101

775

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

317

0.54

1.85

1.1

1.3

49.60

39.34

—

208

(3014111) Lactate [Moles/volume] in Serum or Plasma

1119

10388

1.08

1.83

5.6

7.2

1.29

1.33

mmol/l

0.57

1078

10134

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

155

1902

0.81

1.82

1.1

29.59

6179.13

iu/ml

0.67

449

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.12

1.81

1.1

1.0

2.19

0.32

u/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

214

1.59

1.81

1.6

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

102

787

1.30

1.81

1.1

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

123

1.79

2.3

2.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

580

1.35

1.79

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

737

1.30

1.77

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

131

1.76

1.77

1.4

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

183

1516

1.21

1.76

1.1

3.94

4.01

u/ml

0.02

607

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

208

1.59

1.76

1.0

—

(3000330) Specific gravity of Urine by Test strip

658

5976

1.11

1.75

2.8

3.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

112

879

1.28

1.75

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

264

1.52

1.75

1.2

64.00

71.63

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.03

1.74

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.98

1.74

1.1

1.0

—

(3000492) Spirometry study

1311

12275

1.07

1.73

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

242

2834

0.85

1.73

3.3

3.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.00

1.69

1.1

1.4

337.60

312.63

umol/24h

0.25

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

399

1.41

1.68

1.6

1.9

8.96

9.43

mg/l

0.26

324

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

1.68

0.0

1.1

—

3661.97

—

(3044009) aPTT.lupus sensitive (LA screen)

111

1.80

1.68

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

267

0.52

1.66

2.6

2.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1413

15012

0.93

1.65

6.4

7.2

104.72

104.39

mmol/l

2.09

1413

15003

(3016244) Insulin [Units/volume] in Serum or Plasma

728

1.29

1.65

3.4

3.3

22.68

28.43

mu/l

1.07

688

(40762887) Creatinine [Moles/volume] in Blood

2.80

1.65

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.89

1.64

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

1.69

1.64

1.1

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

145

0.41

1.63

2.0

2.6

0.50

0.63

u/field

—

145

(3036489) Thrombin time

514

4632

1.11

1.61

2.0

2.1

21.09

21.45

0.67

452

4014

(3004588) Protein electrophoresis panel - Serum or Plasma

880

8142

1.09

1.60

2.6

2.3

—

(3048879) Bone marrow aspiration report

337

1.43

1.58

2.1

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

555

0.68

1.56

1.2

1.9

126.26

127.39

umol/l

0.01

280

(3024471) HLA-A [Type]

423

0.64

1.56

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1093

10211

1.08

1.56

2.8

2.6

70.62

66.67

ml/min/173m2

2.88

380

4013

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

577

1.32

1.56

1.2

1.3

4.02

4.32

umol/l

0.42

535

(3050129) First trimester maternal screen panel - Serum or Plasma

309

2706

1.14

1.56

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

138

1128

1.23

1.56

1.1

—

(3044007) Cell count panel - Peritoneal fluid

349

0.60

1.55

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

656

1.30

1.55

2.1

1.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

158

1898

0.83

1.55

1.6

1.3

32.52

34.45

u/l

0.09

138

1640

(3014133) Dog dander IgE Ab [Units/volume] in Serum

192

1621

1.19

1.55

1.1

3.72

3.76

u/ml

0.01

759

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

577

0.69

1.54

3.2

3.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

138

1676

0.82

1.52

1.3

300.20

381.40

pmol/l

0.59

126

1442

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

658

1.29

1.52

2.1

1.9

—

(3002719) Hemoglobin [Mass/volume] in Urine

3.33

1.52

1.0

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1084

11585

0.93

1.52

2.2

374.79

372.48

nmol/l

0.14

998

10648

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

258

1.47

1.49

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.43

1.47

1.0

—

(3015183) Erythrocyte sedimentation rate

600

1.30

1.47

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

859

7975

1.08

1.46

1.3

198.31

222.76

u/ml

0.32

807

7346

(3024561) Albumin [Mass/volume] in Serum or Plasma

5190

53188

0.96

1.46

3.9

4.9

36.62

35.65

g/l

36.07

4779

49526

(3044927) Protein electrophoresis panel - Urine

141

1165

1.21

1.45

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.50

1.45

1.0

1.1

2.57

2.89

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.13

1.44

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

228

1.49

1.43

1.0

0.29

2.03

u/ml

0.85

190

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3244

33553

0.96

1.43

1.6

1.7

1.30

1.38

mmol/l

5.39

2837

28133

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

219

1885

1.16

1.42

1.3

1.4

31.10

30.69

u/l

0.06

175

1539

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.82

1.41

4.7

5.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

447

0.67

1.40

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

623

1.29

1.39

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

599

0.72

1.39

1.3

1.7

1.45

8.25

nmol/l

1.02

495

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

757

1.26

1.38

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.94

1.38

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

288

1.42

1.38

1.1

—

(3014271) Vancomycin [Susceptibility]

537

1.31

1.37

2.6

2.9

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

166

1403

1.19

1.36

1.2

1.1

0.97

2.12

iu/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

617

5669

1.09

1.36

1.4

1.3

31.26

31.15

iu/l

0.03

520

4873

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

460

1.33

1.35

1.1

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

1.34

0.0

2.4

—

4.38

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

175

1.54

1.33

2.3

1.7

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

1.33

0.0

1.0

—

5.92

—

(3032057) Clostridioides difficile [Presence] in Stool

265

1.44

1.33

1.8

—

(3045716) Anion gap in Serum or Plasma

536

0.71

1.33

4.1

2.4

9.24

9.71

mmol/l

0.36

522

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

628

0.73

1.33

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

316

1.39

1.32

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

316

1.39

1.32

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

316

1.39

1.32

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

316

1.39

1.32

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

328

3673

0.89

1.30

1.3

213.63

221.89

miu/ml

0.19

165

1662

(3045142) Bone marrow Pathology biopsy report

160

1355

1.18

1.30

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

1.84

1.29

1.7

1.2

70.43

83.00

umol/l

0.81

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

458

4162

1.10

1.29

1.8

2.3

176.95

591.73

ug/l

7.31

415

3895

(40758292) HTLV I+II Ab panel - Serum

201

1.49

1.29

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

164

1925

0.85

1.29

1.3

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

306

0.62

1.28

1.2

1.3

2.37

317.95

ug/l

—

171

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

161

1.55

1.28

1.2

1.3

—

(3019174) dRVVT (LA screen)

114

1.67

1.27

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

281

2486

1.13

1.27

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.29

1.26

1.0

0.19

0.22

g/l

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

226

2585

0.87

1.26

4.4

5.6

551.62

1921.21

iu/ml

1.20

383

(3024932) HLA-DR beta [Type]

413

0.68

1.26

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1467

13949

1.06

1.26

1.5

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

156

1325

1.18

1.24

1.4

6.55

6.80

g/l

0.39

124

922

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.86

1.23

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

710

0.76

1.23

9.3

12.2

0.60

0.62

mmol/l

0.32

644

(3009214) Lutropin [Units/volume] in Serum or Plasma

358

3224

1.11

1.21

1.4

10.70

11.00

u/l

0.15

284

2602

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.16

1.21

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

383

1.33

1.19

1.3

39.80

39.13

g/l

0.10

204

(37021550) Renin [Units/volume] in Plasma --upright

272

1.40

1.18

1.4

1.3

58.91

72.97

mu/l

0.15

200

(40768795) Lymph node Pathology biopsy report

108

1303

0.83

1.18

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

774

1.23

1.18

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

445

1.30

1.17

1.1

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

155

1325

1.17

1.16

1.4

0.36

0.41

g/l

1.44

124

922

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

959

0.80

1.15

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

130

0.46

1.15

1.2

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.50

1.15

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.50

1.15

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.50

1.15

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.50

1.15

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.50

1.15

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.50

1.15

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

174

2009

0.86

1.14

3.3

3.0

0.73

0.82

nmol/l

2.89

129

1527

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

1.14

0.0

3.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

1.14

0.0

8.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

370

4078

0.90

1.14

2.6

2.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

191

1.47

1.13

1.1

1.64

8.76

u/ml

1.14

142

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

173

1996

0.87

1.13

2.9

2.7

439.73

1995.75

u/ml

1.56

110

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

518

0.73

1.12

3.8

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

379

1.32

1.11

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

102

1228

0.83

1.11

1.9

1.4

279.33

279.46

mosm/kgh2o

0.02

955

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

388

1.32

1.11

1.1

1.2

4.59

26.06

4.08

(3000570) Elastase.pancreatic [Mass/mass] in Stool

410

3741

1.10

1.3

1.4

293.87

272.75

ug/g

1.41

228

2176

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

319

1.35

1.10

1.4

1.6

53.90

109.21

au/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

415

1.30

1.09

3.3

3.2

7.32

7.93

mg/l

0.44

336

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.95

1.08

1.3

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

253

2252

1.13

1.08

1.2

1.5

116.81

114.29

u/ml

0.04

486

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

112

1.61

1.08

1.1

1.0

0.00

3.22

u/ml

—

(3024263) Appearance of Synovial fluid

647

1.24

1.08

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

269

2404

1.12

1.08

1.8

1.9

5.28

5.11

mmol/24h

0.35

230

2134

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

491

5325

0.92

1.08

1.7

1.37

1.56

g/l

5.69

405

4579

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

206

0.58

1.07

2.6

5.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

154

1326

1.16

1.07

1.4

2.87

2.91

g/l

0.12

123

926

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

150

1289

1.17

1.07

2.3

2.4

—

(4062490) Immunoglobulin typing, IgG

154

1327

1.16

1.06

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.76

1.06

1.3

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

217

0.60

1.05

2.8

2.9

11.87

52.56

mg/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.63

1.03

1.1

1.0

0.10

0.67

u/ml

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1108

0.83

1.02

1.3

1.31

1.47

nmol/l

0.81

992

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.73

1.02

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

303

3349

0.90

1.01

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

103

862

1.20

1.01

1.4

1.5

22.29

21.55

u/ml

0.05

176

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2410

23324

1.04

1.01

3.4

3.6

391.59

481.25

ng/l

0.44

1796

17736

(3022493) Free Hemoglobin [Mass/volume] in Plasma

485

0.74

1.01

3.6

5.8

6233.19

494.82

mg/l

0.44

352

(3036180) Methadone [Presence] in Urine

530

0.75

1.01

1.7

2.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

214

0.61

1.00

2.1

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

386

1.30

1.00

2.6

38.84

160.57

au/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1043

9900

1.06

1.00

2.6

67.13

66.52

g/l

2.04

920

9040

(3019230) Fractional oxyhemoglobin in Venous blood

230

2049

1.12

0.99

1.8

3.3

63.04

64.33

0.41

230

2043

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

187

2121

0.88

0.98

1.8

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

906

0.82

0.98

1.8

2.0

1.04

1.99

u/field

1.39

400

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

2.17

0.98

1.0

1.3

1104.48

2309.04

umol/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

834

8833

0.94

0.98

1.6

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

175

0.57

0.97

2.3

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.97

0.0

4.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

148

1.49

0.97

1.4

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.97

0.0

8.7

—

50.50

—

(3001556) Androgen free Index in Serum or Plasma

100

1.60

0.96

1.8

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.96

0.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

138

1593

0.87

0.95

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

614

1.22

0.94

1.0

0.48

1.04

u/ml

0.51

159

(3034274) Bile acid [Moles/volume] in Serum --fasting

146

1268

1.15

0.94

2.1

5.33

8.10

umol/l

1.92

109

929

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

834

0.81

0.93

6.2

6.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

272

2458

1.11

0.93

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

272

2458

1.11

0.93

1.2

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

697

1.21

0.93

1.0

1.1

1.06

1.58

u/ml

0.22

230

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

674

6332

1.07

0.92

7.6

9.3

24.40

24.31

mmol/l

0.38

647

6163

(3012494) Peanut IgE Ab [Units/volume] in Serum

339

0.71

0.92

1.1

0.28

14.61

u/ml

0.76

180

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.14

0.91

1.2

1.0

—

(4034850) Laboratory test

433

4004

1.08

0.91

8.1

9.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

124

1067

1.16

0.91

1.9

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

124

1067

1.16

0.91

1.9

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

124

1067

1.16

0.91

1.9

1.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

110

1.55

0.90

1.1

1.0

0.01

0.22

u/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

1.75

0.90

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

255

0.67

0.90

8.4

4.8

37.24

64.17

u/l

2.04

249

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

113

967

1.17

0.89

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

682

1.20

0.89

1.0

0.38

1.67

u/ml

2.01

171

(3028026) IgM [Mass/volume] in Serum or Plasma

790

7472

1.06

0.88

1.8

1.9

1.41

1.33

g/l

0.39

716

6837

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

177

1.41

0.88

1.1

—

(3008607) Semen analysis panel

1.79

0.87

1.2

1.3

—

(3011985) Renin [Units/volume] in Plasma

158

1793

0.88

0.87

1.4

1.5

69.88

60.52

mu/l

0.22

140

1594

(3038177) Helicobacter pylori Ab [Presence] in Serum

233

2100

1.11

0.86

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

140

1225

1.14

0.84

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

162

1.42

0.84

1.8

2.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

138

0.58

0.83

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

237

2144

1.11

0.82

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

478

4461

1.07

0.82

1.3

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

809

1.18

0.82

1.2

16.17

22.01

u/l

1.41

682

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

754

0.82

0.81

1.1

1.08

1.06

ratio

0.21

264

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

180

1.39

0.81

1.3

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

109

1261

0.86

0.81

2.0

2.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.55

0.81

1.3

1.6

2.22

1.90

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.55

0.81

1.3

1.6

0.67

0.68

mg/l

—

(40757494) Bilirubin.total [Moles/volume] in Blood

687

0.81

0.80

1.8

2.2

37.80

30.87

umol/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

335

3088

1.09

0.79

1.4

101.54

156.77

pmol/l

2.43

328

3010

(3018418) pH of Serum or Plasma

3601

36785

0.97

0.79

3.5

4.1

7.40

0.27

287

7208

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

446

1.23

0.79

1.6

2.0

374.88

35993.02

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

305

0.72

0.79

1.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

430

0.77

0.78

1.1

—

(3045424) Erythrocytes [Presence] in Urine

236

2142

1.10

0.78

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

650

6876

0.94

0.78

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.62

0.78

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

429

1.24

0.77

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.77

0.0

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.77

0.0

1.0

—

0.01

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.77

0.0

1.6

—

1982.00

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1795

17380

1.04

0.77

1.5

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

338

0.74

0.77

1.2

1.3

3.00

3.35

mmol/l

0.37

306

(3051593) INR in Capillary blood by Coagulation assay

511

1.21

0.77

1.0

10.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

162

0.62

0.76

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

414

4438

0.93

0.75

3.5

3.6

460.89

1821.29

u/ml

1.22

353

3792

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

1.1

—

(3014891) Appearance of Pleural fluid

135

0.59

0.73

1.4

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

107

931

1.15

0.72

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

255

2337

1.09

0.71

1.2

1.3

252.85

274.58

u/ml

0.54

166

1488

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

423

0.78

0.71

2.1

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

160

1433

1.12

0.70

1.2

53.12

62.86

u/l

2.78

148

1275

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

413

3863

1.07

0.70

2.2

2.3

93.73

92.41

0.67

399

3708

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

169

1.36

0.69

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

384

3586

1.07

0.68

1.3

815.56

964.31

titre

—

123

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.67

0.68

1.6

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

192

0.68

0.67

1.6

2.9

—

(3051651) Icteric interference index of Serum or Plasma

769

0.84

0.67

2.7

3.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

606

0.82

0.67

1.1

1.3

92.30

65.03

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

441

0.79

0.67

1.5

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

452

0.80

0.67

2.5

2.9

27.59

28.05

umol/l

0.04

339

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

557

1.19

0.67

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.59

0.65

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

168

1857

0.90

0.65

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.57

0.65

1.2

1.1

38.60

24.78

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.57

0.65

1.2

1.1

26.20

18.71

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

367

1.23

0.64

1.3

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6524

64476

1.02

0.64

5.7

6.3

10.99

11.14

umol/l

0.50

6115

61237

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1814

18656

0.97

0.64

2.0

2.1

29.59

29.74

0.54

1773

18120

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

862

0.86

0.64

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

120

1.42

0.64

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

128

1140

1.12

0.64

3.6

3.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

830

1.15

0.63

1.2

76.33

85.50

u/l

0.61

721

(3017509) Phencyclidine [Presence] in Urine

129

0.62

0.63

1.6

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

205

1874

1.10

0.63

1.3

0.57

2.01

nmol/l

1.04

192

1807

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

250

2706

0.92

0.62

1.6

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.55

0.62

3.9

3.3

—

0.00

estimate

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

110

1240

0.89

0.61

1.2

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

182

1.32

0.61

1.5

1.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

367

0.79

0.59

1.2

—

(3023419) Bacteria identified in Sputum by Culture

171

1876

0.91

0.59

2.1

2.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

849

8156

1.04

0.59

2.9

3.3

4.52

4.46

pmol/l

0.79

731

7268

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.5

—

103.29

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.51

0.58

1.0

1.1

321.75

343.74

u/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

300

1.23

0.58

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

511

1.17

0.57

1.3

1.5

—

1484858.79

iu/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

101

895

1.13

0.57

1.2

1.3

1.01

1.81

u/ml

0.94

506

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

144

1589

0.91

0.56

1.0

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3392

33332

1.02

0.56

2.6

2.9

762.24

1211.21

ng/l

21.79

2734

28565

(3029396) Erythrocyte agglutination [Presence] in Blood

241

0.75

0.56

2.3

2.8

—

(3028717) Thiamine [Mass/volume] in Blood

141

1.35

0.56

1.1

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5893

58252

1.02

0.56

2.4

2.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

550

1.16

0.55

1.1

132.92

174.50

iu/ml

1.63

542

(1617658) Protocol used for examination of sentinel lymph nodes

116

1039

1.12

0.55

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1447

14887

0.97

0.55

1.6

1.7

1.38

1.45

2.92

1255

13025

(3021387) Prolactin [Units/volume] in Serum or Plasma

406

3838

1.06

0.54

1.5

1.7

267.70

304.83

mu/l

2.69

366

3469

(3022229) Phosphate [Moles/volume] in Urine

1.50

0.54

1.3

1.9

15.67

18.35

mmol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

213

1.27

0.53

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

267

1.24

0.53

1.6

1.9

4.17

3.23

ug/l

0.18

148

(3017704) Immunofixation for Urine

632

0.85

0.53

1.8

1.6

—

(3025941) Bacteria identified in Stool by Culture

744

7151

1.04

0.52

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

250

1.24

0.52

1.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

183

1986

0.92

0.52

1.5

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

133

1207

1.10

0.51

1.7

1.4

3.76

3.91

ug/l

0.09

113

1021

(21494814) CD8 cells/100 lymphocytes in Specimen

508

1.16

0.51

1.9

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

565

0.85

0.51

1.0

1.1

103.41

95.21

0.93

451

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

203

1879

1.08

0.51

1.3

0.12

0.25

nmol/l

—

134

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

1010

0.89

0.50

1.6

1.9

3.35

3.95

mg/l

1.28

961

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

202

0.74

0.50

1.3

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

289

1.21

0.48

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

110

0.64

0.48

2.7

10.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

185

1997

0.93

0.48

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

185

1997

0.93

0.48

1.8

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

189

1751

1.08

0.48

1.1

1.50

1.51

g/l

0.12

171

1580

(3007566) Smooth muscle Ab [Titer] in Serum

381

3616

1.06

0.47

1.3

63.00

136.55

titre

2.95

325

(3003694) ABO and Rh group [Type] in Blood

3336

33872

0.98

0.46

1.3

1.4

—

(44813793) Dust mix specific IgE antibody measurement

881

1.11

0.46

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.41

0.46

1.1

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

355

1.18

0.46

1.8

2.2

180.00

520.73

e6/l

0.90

191

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

591

0.86

0.46

1.9

2.1

27.88

159.39

ug/min

2.16

131

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

249

2335

1.07

0.46

3.3

3.6

19.38

36.84

u/ml

5.43

240

2263

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

118

0.68

0.45

2.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

120

0.67

0.45

1.1

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1401

13665

1.03

0.45

4.5

4.4

236.57

242.08

u/l

0.95

1292

12938

(3004809) Band form neutrophils/100 leukocytes in Blood

192

2062

0.93

0.44

3.3

1.66

1.56

0.11

169

1855

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

973

10024

0.97

0.44

2.0

2.3

8.17

7.33

ug/l

0.45

812

8807

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

337

3198

1.06

0.43

1.8

4.41

7.19

iu/l

0.51

103

1158

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

104

1.35

0.43

1.4

1.2

103.57

116.92

ug/l

—

(3002582) Erythrocytes [#/volume] in Urine

3718

36690

1.02

0.42

3.2

87.31

83.32

e6/l

0.04

2630

28088

(4212803) Bone marrow aspirate examination

113

1.33

0.42

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.38

0.42

1.2

1.3

0.87

1.17

ml/s/173m2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

185

1.24

0.41

1.8

1.5

0.19

0.25

nmol/l

0.50

127

(40758358) Immune stain study

1.38

0.41

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

889

1.10

0.41

3.2

3.3

99.92

140.44

nmol/l

1.26

879

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.41

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

150

0.73

0.41

1.9

1.7

1.72

1.65

mg/l

0.05

125

(3033923) Metanephrine [Moles/time] in 24 hour Urine

277

1.19

0.41

1.2

1.1

0.67

umol/24h

0.00

133

(3041184) Isoniazid [Presence] in Urine

0.00

0.40

0.0

2.8

—

(3036603) Volume of Urine

863

1.10

0.39

1.6

1983.27

1917.72

0.33

837

(3034426) Prothrombin time (PT)

437

1.14

0.39

1.1

1.2

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.39

0.0

1.2

—

0.59

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

957

9836

0.97

0.39

2.3

2.6

67.57

70.55

e9/l

1.95

689

7451

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.39

0.38

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

182

1705

1.07

0.37

1.3

—

(3013762) Body weight Measured

1.35

0.37

1.4

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

598

0.89

0.36

1.2

146.74

159.73

mmol/24h

0.75

598

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

450

1.13

0.36

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1204

11770

1.03

0.35

2.4

2.2

0.23

0.21

g/l

8.07

1115

10987

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

932

0.91

0.35

1.8

2.1

—

(3042517) Benzodiazepines panel - Urine

124

0.73

0.35

1.1

2.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.40

0.35

2.8

8.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

199

1.21

0.34

1.4

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1284

13101

0.98

0.32

2.3

2.6

1.65

1.79

5.76

1111

11658

(3000285) Sodium [Moles/volume] in Blood

154

0.78

0.32

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

347

3611

0.96

0.31

3.6

3.3

1.77

2.70

ratio

0.53

290

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

186

1759

1.06

0.31

1.7

1.4

0.29

0.37

nmol/l

1.62

141

1309

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.35

0.31

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

261

2492

1.05

0.31

2.1

3.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

7130

71730

0.99

0.30

3.8

4.7

6.42

6.69

mmol/l

31.20

6690

67126

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

200

2104

0.95

0.29

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

312

3246

0.96

0.29

1.7

2.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

733

0.91

0.28

3.1

2.7

40.74

39.50

0.20

420

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

112

1.25

0.28

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

162

0.80

0.28

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

270

1.15

0.28

1.0

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

358

3710

0.96

0.27

3.6

3.4

32.78

46.56

mg/l

1.88

313

2984

(40765096) Chromosome analysis panel by Banding

346

1.13

0.27

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.25

0.27

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

501

0.90

0.27

2.8

2.7

—

(3015736) pH of Urine

4847

48843

0.99

0.27

3.0

3.4

5.86

0.04

472

3671

(3028300) Cannabinoids [Presence] in Urine

436

4225

1.03

0.27

1.6

2.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.21

0.26

2.4

2.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

733

7160

1.03

0.26

3.1

3.6

59.19

54.82

u/ml

0.09

704

6912

(3027008) Opiates [Presence] in Urine

435

4217

1.03

0.26

1.5

2.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

178

1.18

0.26

1.0

1.1

83.14

79.03

ug/l

0.17

147

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

375

3629

1.03

0.25

2.4

2.6

3.50

3.60

g/l

0.71

350

3448

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1363

13849

0.98

0.25

1.7

1.6

—

(3016038) Potassium [Moles/volume] in Urine

778

0.93

0.25

1.2

41.90

35.25

mmol/l

1.11

669

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

105

1.24

0.24

1.8

2.3

—

(40768441) Liver Pathology biopsy report

963

0.93

0.24

1.5

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2945

29731

0.99

0.23

2.2

2.3

2.73

2.93

mg/l

4.57

2370

25552

(3034860) Kappa light chains.free [Mass/volume] in Serum

360

3711

0.97

0.22

3.5

3.4

39.28

69.28

mg/l

1.22

312

2985

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.25

0.22

1.0

1.3

1.34

1.38

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

151

1584

0.95

0.22

1.5

1.6

46.89

57.02

2.56

110

978

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.75

0.22

2.1

5.1

—

(3011288) Drugs identified in Urine by Screen method

288

2787

1.03

0.21

2.2

3.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

21.09

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

33.88

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

578

5652

1.02

0.21

3.2

4.6

24.24

24.17

mmol/l

0.28

567

5541

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

71.31

—

(3001729) Color of Synovial fluid

101

0.79

0.21

1.6

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

837

1.06

0.21

1.0

744.00

727.55

ng/l

0.13

568

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

672

1.07

0.21

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

450

0.91

0.21

1.4

86.99

178.66

nmol/24h

1.31

450

(3000991) Gas panel - Venous blood

1022

10057

1.02

0.20

6.7

8.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

117

1.20

0.20

1.0

1.1

0.00

1.98

u/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

518

1.08

0.20

1.4

2.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.20

0.0

1.0

—

(3013862) HLA-DP [Type]

1.25

0.20

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.22

0.20

1.5

1.3

1099.48

445.26

nmol/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

108

1137

0.95

0.19

2.8

3.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

840

1.06

0.19

1.0

43.15

42.50

ng/l

0.06

576

(3045462) Protein/Creatinine [Ratio] in Urine

122

0.82

0.19

4.5

4.6

15.39

59.63

g/mol

—

103

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

143

0.84

0.18

1.4

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

100

1.20

0.18

1.1

1.2

51.04

42.95

mg/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

147

1.16

0.18

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.19

0.18

1.0

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

621

0.93

0.18

1.1

9.67

15.82

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.13

0.17

1.1

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

835

1.05

0.17

1.0

311.98

328.40

ng/l

0.28

586

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

299

0.90

0.17

1.1

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.72

0.16

1.2

1.1

7.85

8.26

mmol/l

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

166

1721

0.96

0.16

2.7

2.6

4.94

949.45

u/ml

1.06

166

1700

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.71

0.16

1.6

1.7

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

120

1.17

0.16

1.0

0.03

0.12

u/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

546

0.93

0.16

3.0

2.3

52.16

52.27

umol/l

0.01

468

(3019309) Folate [Moles/volume] in Red Blood Cells

2200

21816

1.01

0.16

1.6

1.7

1053.78

1167.41

nmol/l

6.86

1490

16591

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.76

0.15

1.8

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.15

0.15

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

427

4188

1.02

0.14

1.6

2.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.81

0.14

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.79

0.14

2.0

2.1

—

(3002619) Bacteria identified in Specimen by Culture

246

1.10

0.14

1.1

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

353

1.08

0.14

1.3

1.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.19

0.14

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

400

4076

0.98

0.13

1.5

—

(3011648) Oxygen content in Venous blood

939

0.96

0.13

2.2

2.6

11.63

11.05

0.69

939

(3016879) Cocaine [Presence] in Urine

397

3897

1.02

0.13

1.6

2.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

132

1.14

0.13

1.1

1.3

3.82

4.40

nmol/l

0.26

126

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

559

1.06

0.13

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

559

1.06

0.13

1.4

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

106

0.85

0.13

1.3

2.7

527.22

424.98

umol/l

—

100

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

142

1.13

0.12

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.18

0.12

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

748

7572

0.99

0.12

3.0

3.7

5.08

5.15

kpa

1.98

695

7190

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

855

0.96

0.12

1.6

1.5

6.75

6.80

u/l

0.01

685

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

940

9305

1.01

0.11

3.0

3.9

73.21

89.85

ng/l

11.96

801

8059

(3027944) Amphetamines [Presence] in Urine

421

4144

1.02

0.11

1.6

2.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

728

7203

1.01

0.10

3.0

3.6

1.39

1.76

mmol/l

2.62

557

5384

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

830

1.04

0.10

1.4

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

218

0.92

0.10

3.8

3.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

504

0.95

0.10

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

135

0.89

0.09

1.2

1.5

6.52

7.16

mmol/l

—

(3030313) Adrenal Ab [Titer] in Serum

106

1.13

0.09

1.1

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

106

1.13

0.09

1.1

1.0

—

6.08

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

166

0.90

0.09

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

135

1315

1.03

0.09

2.5

3.2

—

(46236302) HLA-C [Type] by High resolution typing

1.06

0.09

1.0

—

(40760410) HLA-B [Type] by High resolution

1.06

0.09

1.0

—

(40760409) HLA-A [Type] by High resolution

1.06

0.09

1.0

—

(40763590) HLA-DQ beta [Type]

1.06

0.09

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

442

0.95

0.09

1.8

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

217

0.92

0.09

7.7

6.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

507

1.05

0.09

2.2

2.4

—

(3012898) Urea [Moles/volume] in Urine

124

0.89

0.09

1.4

231.91

160.33

mmol/l

1.47

108

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

227

0.93

0.09

2.0

18.86

16.65

umol/l

0.59

227

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

196

0.92

0.09

1.3

1.2

112.60

132.21

ng/l

—

130

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.03

0.08

17.7

8.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.81

0.08

1.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.81

0.08

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

381

1.05

0.08

1.5

1.6

9.69

8.93

ug/l

0.54

381

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.14

0.08

1.0

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.08

0.08

1.1

—

19.87

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.06

0.08

1.3

1.6

131.71

165.89

ug/g

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.81

0.07

1.7

1.3

27.00

1369.97

u/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

382

1.05

0.07

1.1

1.3

—

(3047189) Immunofixation for 24 hour Urine

570

1.04

0.07

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.12

0.06

1.0

1.1

8.10

12.15

u/l

—

(3028707) Methadone [Presence] in Urine by Screen method

189

1861

1.02

0.06

1.9

2.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

109

1.10

0.06

2.3

1.6

40.50

43.68

umol/l

0.18

109

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

355

0.96

0.06

1.0

1.6

—

602.40

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.11

0.05

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

242

2392

1.01

0.05

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

151

0.93

0.05

1.0

—

(3009343) pH of Capillary blood

744

7481

0.99

0.05

3.0

3.7

7.42

0.12

985

(4281824) Cell count and differential, peritoneal fluid

151

1531

0.99

0.04

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

131

1329

0.99

0.04

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

229

2311

0.99

0.04

1.4

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

119

0.92

0.03

1.0

1.1

0.01

0.99

u/ml

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4542

45482

1.00

0.03

3.1

3.4

47.53

64.56

ng/l

0.40

2948

30394

(3037756) Immunofixation for Serum or Plasma

245

2469

0.99

0.03

1.8

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

132

1.06

0.02

1.6

2.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

132

1.06

0.02

2.1

3.5

0.71

1.02

mg/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

691

0.98

0.02

1.2

1.1

80.51

83.79

u/l

0.19

620

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

281

1.03

0.02

4.4

3.0

83.38

127.23

ng/l

0.67

117

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

148

1492

0.99

0.02

3.1

3.3

5.07

10.46

nmol/l

0.77

138

1449

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

332

1.02

0.01

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

322

3209

1.00

0.01

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

253

1.03

0.01

3.3

2.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

273

1.03

0.01

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

203

2021

1.00

0.01

1.1

—

(3037121) Protein [Mass/volume] in Urine

419

4183

1.00

0.00

2.8

3.2

0.27

0.31

g/l

0.30

170

1769

(3032868) Hemoglobin electrophoresis panel in Blood

112

0.98

0.00

1.6

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

128

1.02

0.00

1.0

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

132

0.98

0.00

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

268

1.01

0.00

1.6

1.5

85.59

119.84

ng/l

1.43

268

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

545

1.01

0.00

1.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1303

13026

1.00

0.00

3.7

4.1

13.81

24.00

ug/l

0.67

995

10534

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

642

1.00

0.00

1.5

1.8

0.86

2.78

u/field

3.96

467

(3020717) Zinc [Moles/volume] in Serum or Plasma

653

1.00

0.00

1.4

1.5

34.54

25.69

umol/l

1.07

622

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

113

0.97

0.00

6.3

2.4

—

(3050794) Legionella sp Ab [Presence] in Serum

113

0.97

0.00

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

103

0.97

0.00

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

133

0.98

0.00

1.2

1.1

1.69

umol/24h

0.00

133

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

123

1229

1.00

0.00

4.2

4.8

35.86

110.37

u/ml

3.53

365

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

481

1.00

0.00

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

151

0.99

0.00

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

151

0.99

0.00

1.7

1.2

4.54

6.02

mmol/l

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.94

0.00

1.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

277.22

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.4

—

10.71

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.89

-0.00

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.02

-0.00

1.0

1.6

—

(3013466) aPTT in Blood by Coagulation assay

0.92

-0.00

1.2

35.57

36.84

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

15.08

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

15.60

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.92

-0.00

5.7

4.6

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.01

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_SPIROCHAETAL_WIDE – Other spirochaetal diseases

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other spirochaetal diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other spirochaetal diseases (AB1_OTHER_SPIROCHAETAL_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints